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Abstract 
Genome mining was conducted on putative genes from the bacteriocin producing pln locus 
in Lactobacillus plantarum. The bacteriocins plantaricin NC8 and the putative plantaricin J51 
were tested for activity among many different indicator strains, related to the producing 
strains. Plantaricin J51 was established as a novel two-peptide bacteriocin. A narrow 
spectrum of inhibition was observed for both bacteriocins, which is typical for class IIb 
bacteriocins.  
Among the strains sensitive for plantaricin NC8, L. sakei NCDO 2714 and L. plantarum 2-1 
were transformed with the putative immunity gene plNC8c (which is assumed to confer 
immunity to plantaricin NC8) and heterologously expressed. Soft agar assays and microtiter 
plate assays of transformed strains revealed an increase in immunity to plantaricin NC8. 
plNC8c was thus established as a novel bacteriocin immunity gene. No cross-immunity was 
observed. L. plantarum DSM 20174 was transformed with the putative immunity gene J51-
Orf5 (which is assumed to confer immunity to plantaricin J51) and heterologously expressed. 
Soft agar assays and microtiter plate assays however were too ambiguous for any 
conclusions to be drawn. Nevertheless it is very likely that J51-Orf5 functions as an immunity 
gene. 
Protein expression studies were conducted on L. sakei NCDO 2714 expressing the PLNC8C 
immunity protein with an N-terminal FLAG™-tag. The immunity protein was purified using 
immunoprecipitation with an ANTI-FLAG™ antibody bound to a resin complex.  Detection 
levels were low, suggesting a low expression level. No receptor was identified, although this 
study suggests that disulfide bridge complex formation might be involved in immunity 
function. 
Further sequence analyses revealed a “contaminant” open reading frame present in the 
plNC8c immunity gene which might explain high backgrounds and low presence of the 
protein in purification and detection steps. These finding do however not interfere with the 
function of the immunity gene.  
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Sammendrag 
“Genome mining” ble utført på antatte gener fra det bakteriosin produserende pln locuset i 
Lactobacillus plantarum. Bakteriosinene plantaricin NC8 og det antatte plantaricin J51 ble 
testet for aktivitet blant en rekke ulike indikatorstammer, som alle er beslektet med de 
produserende stammene. Plantaricin J51 ble etablert som et nytt to-peptid bakteriosin. Et 
smalt spekter av hemming ble observert for begge bakteriosinene, noe som er typisk for 
klasse IIb bakteriosiner.  
Blant stammene som var sensitive for plantaricin NC8, ble L. sakei NCDO 2714 og L. 
plantarum 2-1 transformert med det antatte immunitetsgenet plNC8c og uttrykt heterologt. 
Dette genet er antatt å gi immunitet til plantaricin NC8.. Mykagaranalyser og 
mikrotiterplateanalyser av de transformerte stammene avslørte en økning i immunitet for 
plantaricin NC8. plNC8c ble derfor etablert som et nytt bakteriosin immunitetsgen. Ingen 
kryssimmunitet ble observert. L. plantarum DSM 20174 ble transformert med det antatte 
immunitetsgenet J51-Orf5 (som er antatt å gi immunitet til plantaricin J51) og uttrykt 
heterologt. Myk agar analyser og mikrotiterplateanalyser var for diffuse til å trekke en 
konklusjon. Uansett er det meget sannsynlig at J51-Orf5 gir immunitet. 
Proteinuttrykkstudier ble utført på L. sakei NCDO 2714 som uttrykker PLNC8C 
immunitetsproteinet med en N-terminal FLAG™-tag. Immunitetsproteinet ble renset ved 
hjelp av immunopresipitering med et ANTI-FLAG™ antistoff bundet til et resinkompleks. 
Deteksjonsnivået var lavt, noe som tyder på et lavt uttrykk av proteinet. Ingen reseptor ble 
identifisert, men denne studien antyder at opprettelsen av et disulfidbro kompleks er 
involvert i immunitetsfunksjonen.  
Videre sekvensanalyser avslørte en “kontaminerende” åpen leseramme tilstede i plNC8c 
immunitetsgenet som kanskje kan forklare høy bakgrunn og lav tilstedeværelse av proteinet 
i rensing- og deteksjonsstegene. Dette funnet fører ikke til forstyrrelser for funksjonen av 
immunitetsgenet.  
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Abbreviations 
aa Amino acid(s) 
bp base pair(s) 
dH2O Distilled water 
dsDNA double stranded DNA 
DTT Dithiothretiol 
EDTA Ethylenediaminetetraacetic acid 
g gram(s) 
LAB Lactic Acid Bacteria 
min Minute(s) 
ON Over Night 
PTM Post Translational Modifications 
rpm Revolutions per minute 
RT Room Temperature 
sec Second(s) 
ssDNA single stranded DNA 
Tm Melting temperature1 
 
                                                     
1 As defined by Santa Lucia (1998) 
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1 Introduction 
 Lactic Acid Bacteria (LAB) 1.1
Lactic acid bacteria are Gram-positive bacteria belonging to the low G+C group in the phylum 
Frimicutes (Sneath et al. 1986). This phylum contains three classes, in which LABs are found 
in the class Bacilli (sometimes also referred to as Firmibacteria). 
LABs are characterized by their ability to produce lactic acid as one of the major end-
products of the carbohydrate fermentation pathway (Felis & Dellaglio 2007).They usually 
lack cytochromes, and are thus dependent on carbohydrate fermentation to fuel their 
substrate-level phosphorylation. LABs are also usually non-motile (meaning they do not 
possess flagella) and do not form endospores (Sneath et al. 1986).  LABs belong to the order 
Lactobacillales which has many genera including Enterococcus, Lactococcus, Lactobacillus, 
Leuconostoc, Streptococcus and Pediococcus (Wiley et al. 2010). 
 The genus Lactobacillus   1.1.1
The bacteria belonging to the genus 
Lactobacillus are non-motile and non-
sporulating rods or coccobacilli (Tannock 
2004). They have complex nutritional needs, 
which are reflected in their natural habitat. 
They are usually found in carbohydrate rich 
environments like in plants, food, spoiled 
food and in the intestine of humans and 
animals (Hammes & Vogel 1995). In the 
large intestine, however, simple 
carbohydrates are not available for 
fermentation, so the lactobacilli residing 
there are dependent on other microorganisms to degrade complex carbohydrates (like plant 
materials) and make them available to the lactobacilli (Balows et al. 1992). Although they are 
present in the gut microflora of various animals, very few of them are pathogenic (Claesson 
Figure 1.1 Lactobacillus plantarum as viewed 
through an electron microscope (Wiley et al. 
2010). The bacteria has been artificially colored. 
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et al. 2007). Over 100 species are known (per February 2007), and this makes the genus one 
of the largest groups of LABs (Felis & Dellaglio 2007). 
Lactobacilli are widely used in the food industry in production of foods that require 
fermentation (Tannock 2004). Most of these products are dairy products like yoghurt and 
different cheeses, but also in other products like pickles, sauerkraut and salami, can 
lactobacilli be found in the starter cultures. Because lactobacilli are found as starter culture 
in food, lactobacilli and their secreted products are classified as GRAS (Generally Recognized 
as Safe) by the US Food and Drug Administration (Guarner & Schaafsma 1998). This has led 
to a tremendous increase in the use of lactobacilli in different probiotic dietary supplements. 
Humankind may have passively benefited from lactobacilli since the dawn of fermented food 
production, as many lactobacilli secrete compounds that can inhibit the growth of unwanted 
pathogens. However, lactobacilli are also involved in food spoilage, and care must therefore 
be taken not to introduce food-spoiling lactobacilli, while preserving the beneficiary flora 
during food fermentation. 
Lactobacilli may ferment glucose homofermentatively (more than 85% of the fermentation 
products is lactic acid), using the Embden-Meyerhof pathway, or heterofermentatively 
(producing lactic acid, carbon dioxide, ethanol and/or acetic acid in equimolar amounts), 
using the phosphoketolase pathway (Figure 1.2) (Tannock 2004). This ensures that their 
environment is slightly acidic, which is reflected in the optimum pH range for lactobacilli, 
which is also slightly acidic (between pH 4.5 and 6.4). This means that lactobacilli cannot 
rapidly colonize any new habitats directly, but must hold out until the pH is within 
acceptable limits. The lactate secreted by lactobacilli is one of many substances that they 
secrete which creates an environment that is unfavorable to other bacteria. This gives them 
a competitive advantage over other bacteria which have a more efficient energy metabolism 
(i.e. oxidative phosphorylation instead of substrate-level phosphorylation). Therefore the 
lactobacilli can out-compete unwanted bacteria in the gut, and this property is also 
considered as an important probiotic characteristic (Tortora et al. 2007). Another compound 
which lactobacilli secrete in order to gain an advantage over other bacteria is small 
antimicrobial compounds called bacteriocins. 
  1. Introduction 
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Figure 1.2 Overview of different fermentation pathways used by LABs (Adams & Moss 2008). 
Lactobacilli usually employ only one of the pathways, although some can utilize both. 
 The genus Pediococcus  1.1.2
The bacteria belonging to the genus Pediococcus are non-motile cocci (Carr et al. 2002). They 
ferment glucose homofermentatively (using the Emden-Meyerhof pathway) and they 
tolerate a lower pH than several lactobacilli (below pH 4.5). Not many species belonging to 
this genus are known, compared to the well-studied genus Lactobacilli (Felis & Dellaglio 
2007). The species within this genus all lack catalase and they range from aerobic to 
microaerophilic (Carr et al. 2002). Pediococci also have complex nutritional needs, which is 
also reflected in their natural habitats which includes plants, dead plant material and foods. 
Some of the species are also used in the production of fermented foods like pickles, olives, 
sauerkraut, bacon and some fermented sausages. However a few of the species are also 
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known to be food spoilers, like P. damnosis which is a known contaminant in beer, causing a 
cloudy appearance and acid-like taste (Rainbow 1975). Some pediococi are also known to 
cause swelling of cucumbers during pickles production (Carr et al. 2002). Like lactobacilli, 
some pediococci are known to produce substances that have a strong antimicrobial effect. 
One of these substances is a bacteriocin called pediocin PA-1 (Mathys et al. 2007). 
 Bacteriocins 1.2
Bacteriocins are small antimicrobial peptides that can be produced by a vast range of 
bacteria. Both Gram-negative and Gram-positive bacteria produce bacteriocins, but only the 
latter will be discussed here (Jack & Jung 2000). Bacteriocins produced by Gram-positive 
bacteria share many of the same attributes as the ones produced by Gram-negative bacteria 
(Duquesne et al. 2007). 
Bacteriocins are gene encoded, meaning that most of the information present in the mature 
peptides can be found in just one gene (Cotter et al. 2005). Some bacteriocins are post-
translationally modified, and some bacteriocins require two peptides to exert antimicrobial 
activity, thus also requiring information from more than one gene (Nissen-Meyer et al. 1992; 
Skaugen et al. 1994). This is unlike other antibiotics, which is usually a product formed by 
many different enzymes, each modifying parts of the substrate, leading up to the formation 
of the finished antibiotic compound (Kieslich 1986). This requires the information from 
several genes. Immunity for both bacteriocins and antibiotics is usually encoded by a single 
gene which is present in the producing strain (Diep et al. 2009). 
 Most bacteriocins have a narrower field of inhibition than antibiotics. Bacteriocins are often 
active against antibiotic-resistant pathogenic bacteria, and could therefore be used in clinical 
treatments of infections (Kruszewska et al. 2004). For example, bacteriocins could be useful 
for treatment of infections caused by nosocomial antibiotic-resistant bacteria, as antibiotic 
resistance is becoming an increasing problem in hospital environments. Clostridium difficile 
is an example of such a bacterium, which is becoming ever more resistant to antibiotics, but 
still remains sensitive to some bacteriocins produced by LABs (Rea et al. 2010). The 
bacteriocin thuricin CD, which has a very narrow spectrum of inhibition, has been shown to 
specifically eliminate C. difficile, without a large impact on the indigenous bacterial 
community in the gastrointestinal tract (Rea et al. 2011). Thuricin CD may therefore be a 
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viable alternative in the treatment of C. difficile- associated intestinal diseases, as the 
current method by using broad-spectrum antibiotics often leads to recurring infections and 
problems with antibiotic resistance (Aslam et al. 2005). 
The typical mode of action used by bacteriocins to kill bacterial cells is to permeabilize the 
cell membrane (Nes et al. 2007). This is probably in most cases achieved by the binding of 
the bacteriocin to a receptor on the cell membrane, which in turn creates a pore in the 
membrane, allowing the free flux of ions and other small molecules (like K+, PO43-, H+) over 
the membrane. This eliminates the proton motive force, effectively killing the cells. Pore 
size, stability and selectivity of transferable molecules vary between different bacteriocins 
(Eijsink et al. 2002). Not all bacteriocins bind to a receptor in the cell membrane. Nisin binds 
to lipid II, a part of the bacterial cell wall synthesis machinery situated in the cell wall 
(Breukink & de Kruijff 2006). Upon binding of nisin, pores containing both nisin and lipid II 
are formed (Hsu et al. 2004). Independently of pore formation, cell wall synthesis is also 
blocked upon binding of nisin to lipid II (Hasper et al. 2006). Although bacteriocins have been 
studied in great detail, only a few receptors and how bacteriocins interact with them have 
been studied in detail. 
 Classification of bacteriocins from LABs 1.2.1
The LAB bacteriocins constitute a large and heterogeneous group of bacteriocins. They vary 
in their peptide size, post translation modifications, chemical stability and mode of action. It 
is therefore practical to employ a classification scheme to further group the different 
bacteriocins. Although the bacteriocins are usually given names deriving from the producing 
strain, this does not imply that bacteriocins from taxonomically close strains, or even 
bacteriocins produced from the same strain have the same properties. 
Constructing a classification scheme for the LAB bacteriocins is not a straightforward task. 
This has led to the use of several classification schemes (Cotter et al. 2005; Nes et al. 2007). 
The classification from Nes et al. (2007) will be used here, as it one of the most used 
classification schemes, while also building upon one of the first broadly accepted 
classification schemes (Figure 1.3) (Klaenhammer 1993).  
Class I (Lantibiotics) bacteriocins consist of post translationally modified bacteriocins, which 
are characterized by several ring structures known as lanthionine or β-methyllanthionine, 
  1. Introduction 
6 
 
giving the name to this class (Bonelli et al. 2006). The lantibiotics may also contain other post 
translationally modified amino acids (like D-alanine) (Skaugen et al. 1994). The Class III 
(Large, heat-labile) bacteriocins consist of antimicrobial proteins rather than peptides, but 
are still included in the classification. The unmodified cyclic bacteriocins belong to class IV 
(Cyclic bacteriocins) (Nes et al. 2007). Class II, which consist of non-modified, heat-stable 
bacteriocins, is the largest and most studied group, and these bacteriocins are discussed in 
section 1.2.2.  
 
Figure 1.3 Classification of LAB Bacteriocins according to Nes et al. (2007). *Class III consists of 
proteins rather than peptides, however, this group is still included within the classification scheme.  
 
 Non-modified, heat-stable bacteriocins (Class II) 1.2.2
Members of this class are divided into several subclasses. Class IIa (pediocin-like) 
bacteriocins are characterized by an N-terminal consensus motif YGNGVxCxxxxCxVxWxxA 
(where x is any amino acid, and the underlined aa are fully conserved). These bacteriocins 
seems to contain two distinct domains; one highly conserved, cationic and hydrophilic N-
terminal region, and one less conserved and more hydrophobic C-terminal region (Nissen-
Meyer et al. 2009). Structures have been resolved for four Class IIa bacteriocins; sakacin P, 
leucocin A, curvacin A and carnobacteriocin B2 (Fregeau Gallagher et al. 1997; Haugen et al. 
LAB Bacteriocins 
Class I  
Lantibiotics 
Class II            
Non-modified 
heat-stable 
bacteriocins 
Class IIa  
Pediocin-like 
bacteriocins 
Class IIb          
Two-peptide 
bacteriocins 
Class IIc            
The unsorted 
bacteriocins 
Class IId 
Leaderless 
bacteriocins 
Class IIe     
Protein-derived 
bacteriocins 
Class III*         
Large, heat-labile 
bacteriocins 
Class IV          
Cyclic 
bacteriocins 
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2005; Uteng et al. 2003; Wang et al. 1999). This subclass has again been divided into several 
subgroups based on the amino acid sequence of the bacteriocins (Nissen-Meyer et al. 2009). 
Over 35 bacteriocins belonging to Class IIa are known. Pediocin PA-1 is an example of a Class 
IIa bacteriocin (belonging to subgroup 1) (Nissen-Meyer et al. 2009). It is also shown to have 
a strong activity against the food borne pathogen Listeria monocytogenes (Rodriguez et al. 
2002). What is peculiar about this bacteriocin is that it forms a disulfide bridge in its tertiary 
structure, which is necessary for the bacteriocin to display any microbial activity. Thus 
subjecting the bacteriocin to denaturing conditions (like Dithiothretiol or 2-
mercaptoethanol) will abolish the antimicrobial activity of the peptide. The receptor for 
Class IIa bacteriocins have been determined to be a specific part of the Mannose 
Phosphotransferase System (Kjos et al. 2009; Kjos et al. 2010a). The exact mechanism is not 
known, but it is suggested that the bacteriocin binds to and induces a conformational change 
in the man-PTS IIC protein, which creates a pore in the target membrane (Kjos 2011). 
The bacteriocins belonging to class IIb require the combined action of two different peptides 
for optimal activity, and these are discussed in section 1.2.3. Class IId consists of bacteriocins 
lacking any leader sequences. Eight bacteriocins belonging to class IId are known (Nes et al. 
2007). Although the peptides lack the leader sequence in which other bacteriocins are 
dependant on for secretion, the class IId bacteriocins seem to utilize the same dedicated 
transport mechanism as other class II bacteriocins (The ABC transporter, discussed in section 
1.2.4). Class IIe consists of peptides derived from degradation of larger proteins. Only four 
bacteriocins belonging to this subclass are known. The best studied class IIe bacteriocin is 
Propionicin F. This bacteriocin has 43 residues, which are processed from a protein 
containing 255 residues (Brede et al. 2004). The processing involves both N-terminal and C-
terminal processing of the protein in order to yield the mature bacteriocin peptide. The non-
modified heat-stable bacteriocins that do not fit any other subclass are grouped in class IIc 
(the unsorted bacteriocins) (Nes et al. 2007). Lactococcin A is the best studied class IIc 
bacteriocin. It has a very narrow range of inhibition, and its potency also varies between 
sensitive strains (Holo et al. 1991). It also lacks the characteristic N-terminal consensus motif 
typical of class IIa bacteriocins, and is therefore grouped in class IIc. Lactococcin A utilizes the 
same receptor as class IIa bacteriocins, which is the mannose PTS (Diep et al. 2007). 
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 Two-peptide bacteriocins (Class IIb) 1.2.3
The bacteriocins belonging to subclass IIb differ from other class II bacteriocins in that they 
require the synergistic activity of two peptides to exert antimicrobial activity (Oppegard et 
al. 2007). Although some of the peptides can show antimicrobial activity individually, this is 
greatly increased by addition of the complementary peptide (Jimenez-Diaz et al. 1995). 
Together, the two complementary peptides are active at the nanomolar to picomolar range 
(Nes et al. 2007). Even though the two peptides functions as one bacteriocin unit, the single 
peptides are very similar to the one-peptide bacteriocins from Class IIa (Pediocin-like 
bacteriocins) in the physical sense. They both contain amphiphilic and hydrophobic regions 
and they are mostly cationic. The genes encoding the two different peptides are also closely 
associated genetically, being encoded in the same operon (Diep et al. 2009). Over 17 
different class IIb bacteriocins have been characterized (Oppegard 2010). 
Three-dimensional structures of some class IIb bacteriocins have been elucidated. Among 
them are the well-studied lactococcin G and the plantaricins EF and JK (Fimland et al. 2008; 
Rogne et al. 2008; Rogne et al. 2009). See Figure 1.5 for an overview of peptides constituting 
plantaricin JK. These peptides are unstructured in aqueous solution, but become structured 
in membrane mimicking environments. As shown in Figure 1.5, the structures are dominated 
by a defined central α-helical region (pink color) flanked by flexible regions (white color) in 
the ends. No three-dimensional structures have been determined for any peptide 
heterodimers, but a direct physical interaction between the complementary peptide, when 
exerting microbial activity has been shown (Hauge et al. 1999). More specifically, the 
peptides constituting Lactococcin G (LcnG-α and LcnG-β) are proposed to interact with each 
other through certain parts of the α-helical domains in each peptide (Oppegard et al. 2008). 
This interaction only occurs in membrane mimicking environments (see Figure 1.4). 
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Figure 1.4 Schematic overview of proposed structure of Lactococcin G when exerting anti-microbial 
activity (Oppegard et al. 2008). The two peptides interact through the GxxxG-motifs found in the α-
helical regions of both peptides. 
The inhibitory spectrum of class IIb bacteriocins is very narrow; plantaricins EF and JK are 
only active against a few strains of Lactobacillus and Pediococcus as this study also shows 
(Anderssen et al. 1998). 
 
Figure 1.5 Three-dimensional structures of individual peptides constituting plantaricin JK. N- and C-
termini are indicated. Structures visualized using FirstGlance in Jmol (http://firstglance.jmol.org/). 
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Similar to other class II bacteriocins, class IIb bacteriocins kill target cells by pore formation. 
However, the molecular mechanism underlying this process is completely unknown, and no 
target receptor for any class IIb bacteriocins have been identified. 
 The bacteriocin producing plantaricin locus 1.2.4
Plantaricins EF and JK are both translated from the same locus called the plantaricin locus in 
select L. plantarum strains (Diep et al. 2009). Five different loci, from different strains of L. 
plantarum have been studied so far (C11, WCSF1, NC8, J51 and J23), revealing a mosaic 
composition of genes between the different strains. See Figure 1.6. 
 
Figure 1.6 Overview of the mosaic plantaricin locus adapted from Diep et al. (2009). Lollipops 
indicate promoter sites. brnQ1 and napA1 are not part of the pln locus (only shown as upper 
boundaries). Lower ends of NC8 and J51 and pln loci are not completely sequenced. pln loci 
sequence from J23 is not shown. 
As also observable from Figure 1.6, the single peptides constituting plantaricin EF and JK are 
transcribed together with their cognate immunity genes (plnI and plnL respectively) from the 
same  operons (Nes et al. 1995). The class II bacteriocins usually contain a so called double 
glycine leader sequence at the N-terminal of the peptide. This sequence has the consensus 
motif LSxxELxxIxGG (where x is any amino acid) where the second last glycine is fully 
conserved (Nes et al. 1996). This leader sequence suppresses the activity of the peptide 
while inside the producing cell. It also serves as a recognition motif for the ATP-Binding 
Cassette (ABC) transporter on which the peptide binds and is secreted out of the cell 
(Havarstein et al. 1995). The leader sequence is cleaved off during translocation over the 
membrane by dephosphorylating a bound ATP molecule, using the energy to secrete the 
peptide. The dedicated ABC transporter thus contains a proteolytic N-terminal domain, 
which acts as a protease when removing the leader sequence. The ABC transporter (plnG) 
requires an accessory protein (plnH) in order to secrete the bacteriocin peptides, however, 
  1. Introduction 
11 
 
the mechanism of interaction between the accessory protein and the ABC transporter 
remains unknown. 
Although some bacteriocin production systems have been reported to be constituently 
active, many lactobacilli employ a tight regulation of bacteriocin production to avoid wasting 
energy when bacteriocin production is not needed (Eijsink et al. 2002). The mechanism 
behind the regulation is based on a so called three-component regulatory system, which is a 
quorum sensing based system (Nes et al. 1996). The three components consist of a secreted 
inducer peptide, a transmembrane histidine kinase, and a response regulator (usually a 
transcription factor). The inducer peptide (plnA) is translated and exported to the outside of 
the cell, with the help of the same ABC transporter used to secrete bacteriocin peptides. 
When the concentration of inducer reaches a certain threshold, it binds to the histidine 
kinase (plnB), triggering a cascade reaction chain that eventually leads to the 
phosphorylation and activation of the response regulator (plnC and plnD) inside the cell. This 
response regulator specifically binds to select promoter areas as homodimers and activate 
transcription of target genes (Risoen et al. 1998). L. plantarum NC8 does not contain the 
same histidne kinase (plnB), response regulator (plnC) and induction factor (plnA) as the 
other studied strains. Instead the NC8 strain relies on a different histidine kinase (NC8-HK) 
which is situated in the same area where the plnB gene would be (Maldonado-Barragan et 
al. 2009). The response regulator gene plnC is also absent in strain NC8, suggesting that only 
plnD is needed. The induction factor plnA is also replace with another gene, NC8-IF, which 
serves the same function. The bacterial population uses this three component system to 
communicate and regulate the production of bacteriocins, as the high concentration of 
inducer peptide needed to surpass the threshold level, is only achieved at high cell densities. 
The precise mechanism on how many of the immunity proteins confer immunity to the 
producing host is not known. As the immunity genes have a conserved location, many 
putative immunity proteins have been discovered. These proteins vary greatly in sequence 
length, composition and structure, suggesting a vast repertoire of different immunity 
mechanisms. Recently, the immunity genes conferring immunity for plantaricins EF and JK 
(plnI and plnL respectively) have been studied, showing that these immunity genes belong to 
the Abi protein family (Kjos et al. 2010b). The Abi protein family has been characterized in 
eukaryotes, but any activity or molecular function has not been deduced in bacteria. The Abi 
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proteins functions as zinc dependent proteases in eukaryotes, specifically targeting the C-
terminal sequence CAAX (where A  and X are any aliphatic and any residue respectively) (Pei 
& Grishin 2001). Certain residues in the conserved motifs seem to be important in 
maintaining bacteriocin immunity, although any proteolytic activity by the bacterial 
immunity proteins has not been shown. However, several putative genes with a CAAX 
protease signature are present in the pln locus (plnP, plnT, plnU, plnV and plnW), but any 
function for these genes have not been deduced (Diep et al. 2009). The precise mechanism 
behind the immunity function has yet to be unraveled.  
As observable from Figure 1.6 several putative genes with unknown function (like plnN and 
plnO), bacteriocin genes and their immunity genes have yet to be experimentally verified. 
This represents a new issue as several genomes from Lactobacillus are being sequenced, but 
experimental data confirming the authenticity of the putative genes is missing. Since many 
bacteriocin related operons contain conserved sequences, they are easy to assign to novel 
sequences. In order to verify the function of such genetic elements, the approach of 
searching sequenced genomes for putative bacteriocin elements, and then expressing and 
verifying them experimentally, has proven successful in previous studies (Begley et al. 2009). 
The two-peptide bacteriocin of the plantaricin locus, plantaricin NC8 has been characterized 
(Maldonado et al. 2003). The putative immunity gene (plNC8c) however, remains to be 
experimentally determined. The plNC8c gene is believed to harbor three transmembrane 
helices which are necessary for membrane insertion. The J51 operon containing the putative 
plantaricin J51 and its immunity gene (J51-Orf3, J51-Orf4 and J51-Orf5 respectively) is even 
more unexplored, as none of the ORFs have been determined experimentally (Navarro et al. 
2008). 
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 Aim of this study 1.3
The focus of this study will be to examine the putative immunity genes plNC8c and J51-Orf5 
and the putative plantaricin J51 genes (J51-Orf3 and J51-Orf4). 
• Examine the sensitivity of plantaricin NC8 and the putative plantaricin J51 among 
different strains. 
• Express the respective putative immunity genes in sensitive strains and examine if 
sensitivity is altered. 
• Examine if the putative immunity genes are being expressed and look for possible 
receptor candidates. 
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2 Materials 
 Bacterial strains 2.1
Name LMGT 
number 
Growth 
Temperature 
(°C) 
Comments1 
Escherichia coli  37  
 DH5α®   Used for cloning 
 DH5α® pMG36e 2702  Contains pMG36e, used as 
control plasmid 
 B276   Contains p363, used as vector in 
cloning 
Lactobacillus acidophilus   37  
 NCDO 1748 2303   
 ATCC 3456 2712   
L. amylophilus NCDO 2503 2300 30  
L. amylovorus NCDO 2657 2301 30  
L. casei NCDO 2743 2324 30  
L. cellobiosus NCDO 927 2306 30  
L. coryneformis NCDO 2741 2309 37  
L. curvatus  30  
 NCDO 2739 2310   
 CTC 435 2371   
 89 2355B   
 BCS35 3291   
L. delbrueckii NCDO 213 2331 37  
L. fermentum ATCC 9338 V 2716 37  
L. helveticus ATCC 15009 2761 37  
L. plantarum  37  
 965 2003   
 R 2352   
 DSM 20174 2378  Used for heterologous 
expression 
 AA23 2389   
 ACA-DC 289 3160   
 2-1 3176  Used for heterologous 
expression 
 2-2 3177   
 ACA-DC 3333   3215   
 ACA-DC 3341 3216   
 ACA-DC 3342 3217   
 NC8   Used to isolate plNC8c gDNA 
L. rhamnosus GG 3087 37  
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L. salivarius 83 3494 37  
L. sakei  30  
 MK326   Expresses part of sakacin 23K 
 MK327   Expresses part of sakacin 23K 
 2F13 3147   
 23K 3051   
 64F 3052   
 NCDO 2714 2313  Used for heterologous 
expression 
 CTC A4 2373   
 460 2376   
 DSM 20017 2377   
 706 2334   
 45 2340   
 77 2360   
L. viridesence NCDO 1655 2314 37  
Lactococcus lactis  30  
 IL1403 B244  Contains p369, used as control 
in SDS-PAGE 
 MG1363 2144   
Leuconostoc mesenteroides 
Y105 
3081 30  
Pediococcus acidilactici 2351 30 Produces pediocin PA-1 
P. pentosaceus NCDO 990 2315 30  
1 All strains without specific comments were used in the screening for bacteriocin sensitive strains. 
 Equipment and instruments 2.2
Type  Model(s) Manufacturer 
Agarose gel vessels  Amersham Biosciences 
Autoclave SC 500 Matachana 
Balance XF-3200 Salter 
Balance ER-182A Salter-And 
Balance CP2202S Sartorius 
Centrifuge 5804R Eppendorf 
Centrifuge, large J2-21M/E Beckmann 
Centrifuge, large RC6 Sorvall 
Centrifuge, tabletop 541D Eppendorf 
Centrifuge, tabletop, refrigerated Biofuge Fresco Heraeus 
DNA Sequencer ABI Prism 377 Applied Biosystems™ 
Electroporation apparatus Pulse Controller Bio Rad® 
Electroporation apparatus Gene Pulser™ Bio Rad® 
FastPrep™ FP 120 BIO 101 
Film Amersham Hyperfilm™ ECL GE Healthcare 
Freezer  -20°C Freezer Whirlpool 
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Freezer -86 °C Freezer Forma Scientific 
French press cell French® Pressure Cell Aminco® 
Fume hood  Kebo Healthcare Systems 
Gas burner Fireboy and flameboy Integra Biosciences 
Gel doc Benchtop UV UVP 
Ice machine KF85 Porkka 
Incubator  Termaks 
Incubator Series 25 New Brunswick Scientific Co. 
Inc 
Microtiter plate scanner Multiskan® Ascent Labsystem 
Microwave oven M182DN and M172N Samsung 
Nanodrop Spectrophotometer ND-1000 NanoDrop® 
pH Meter MP 220 Mettler Toledo 
Plate colony counter Colony Counter Gallenkamp 
Power Supply PS 250 and PS 500XT Hoefer Scientific Instruments 
Power Supply Power Pac 300 Bio Rad® 
Refrigerator Grand Cooler Bosch 
Rotary Mixer Multi Bio RS-24 Biosan 
SDS-PAGE equipment  Bio Rad® 
Shaker, large KL-2 Edmund Bühler 
Shaker, small PS-3D Grant Instruments 
Spectrophotometer Colorimeter 252 Ciba-Corning 
Sterile benches TL 2472 Holten 
Sterile benches  KEBO Production 
Thermocycler MyCycler™ and S1000™ Bio rad 
Thermocycler PTC-100™ MJ Research, Inc.  
Thermocycler Mastercycler gradient Eppendorf 
Vortex  mixer G-560E Sicentific Industries 
Vortex mixer MS2 Minishaker IKA® 
Water bath 6A Julabo 
Water bath, 55°C TW20 Julabo 
Water System Milli-Q Millipore 
Western blot chamber Hypercasette™ Amersham Life Science 
Western blotting system Mini Trans-Blot System Bio Rad® 
 
 Kits 2.3
Kit Supplier 
ABI PRISM® BigDye® Terminator v3.1 Cycle Sequencing 
Kit 
Applied Biosystems 
E.Z.N.A  Plasmid Mini kit I Omega bio-tek 
ECL Plus™ Western Blotting Detection Reagents Amersham Biosciences 
Nucleospin® Extract II Macherey-Nagel 
QIAGEN Plasmid Midi Kit Qiagen 
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 Chemicals 2.4
Name of chemical Supplier 
Acetic Acid (glacial) Merck 
Acrylamide/Bis-acrylamide (37.5:1) 40% Serva 
Ammonium Persulfate Shelton Scientific 
Ammonium Sulfate Merck 
ANTI-FLAG® M2 Affinity gel Sigma® 
Anti-FLAG® M2 Antibody Sigma® 
Bacto Agar Saveen Werner AB 
2-merkaptoethanol (β-merkaptoethanol) Merck 
Bovine Serum Albumin (BSA) New England Biolabs 
Bromophenol blue usb® 
Calcium chloride (CaCl2) Merck 
Citric acid Monohydrate Merck 
Development Solution G 153 AGFA 
Disodium carbonate (Na2CO3) Merck 
Disodiumhydrogenphosphate 2-hydrate (Na2HPO4 · 2H2O) VWR International 
Dithiothretiol (DTT) Invitrogen™ 
dNTPs (dATP, dCTP, dTTP) TaKaRa 
Dodecyl Sulfate Sodium Salt (SDS) Merck 
Erythromycin Sigma® 
Ethanol Kemetyl 
Ethidium bromide Sigma® 
Fixation Solution G 354 AGFA 
Formaldehyde – 37% (v/v) Sigma-Aldrich® 
Glass beads, acid washed ≤106µm Sigma® 
Glucose Monohydrate Merck 
Glycerol Sigma® 
Glycine Merck 
Hydrochloric acid fuming 37%(HCl) Merck 
Isopropanol Arcus 
M17 Broth Oxoid 
Magnesium chloride hexahydrate (MgCl2·6H2O) Merck 
Methanol VWR International 
Monopotassium phosphate (KH2PO4) VWR International 
MRS (de mann, Rogosa, Sharpe) Broth Oxoid 
Polyethylene Glycol 1500 (PEG1500) Merck 
Potassium Chloride Merck 
Silver Nitrate (AgNO3) Sigma-Aldrich® 
Skim milk powder Oxoid 
Sodium Chloride (NaCl) Merck 
Sodium Hydroxide pellets (NaOH) Sigma-Aldrich® 
Sucrose Merck 
TEMED Bio Rad® 
Tritiplex III Merck 
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Triton X-100 Sigma® 
Trizma® Base (Tris-base) Sigma® 
Trizma® hydrochloride (Tris-HCl) Sigma® 
Tryptone Oxoid 
Tween-20 Sigma® 
Ultrapure™ Agarose  Invitrogen™ 
Yeast Extract  Oxoid 
 Buffers used 2.5
GYT (Glycerol Yeast Extract Tryptone) contains: 10% (v/v) glycerol, 0.125% (w/v) yeast 
extract and 0.25% (w/v) tryptone. 
GTE (Glucose TE) contains: 50nM glucose, 50mM Tris-HCl pH 8.0 and 10mM EDTA pH 8.0. 
The solution was stored at 4°C. 
Loading Buffer (6x) for agarose gel electrophoresis contains: 40% (w/v) sucrose, 5mM EDTA 
and a few grains of bromophenol blue. 
PBS-T (Phosphate Buffered Saline - Tween) contains: 137mM NaCl, 26.8µM KCl, 10.14mM 
Na2HPO4, 1.76mM KH2PO4 and 0.5% (v/v) Tween-20. The pH was adjusted to 7.4. 
SDS Sample Buffer (2x) contains: 10mM Tris-HCl pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol 
and a few grains of bromophenol blue. When appropriate, 10% (v/v) β-merkaptoethanol was 
added. 
TAE (Tris Acetic EDTA) buffer contains: 40mM Tris-base, 1µM EDTA pH 8.0 and 1.1% (v/v) 
acetic acid. 
TBS (Tris Buffered Saline) buffer (10x): 80g NaCl, 2g KCl and 30g Tris-base was mixed with 1L 
dH2O. pH was adjusted to 7.4 with HCl, and the TBS was then autoclaved and stored at 4°C. 
TE (Tris EDTA) buffer (0.1x) contains: 1mM Tris-HCl pH 8.0 and 100µM EDTA pH 8.0. 
TES (TE with salt) buffer: 10mM Tris-HCl pH 7.5, 100mM NaCl and 1mM EDTA pH 8.0. 
Transfer buffer for Western blotting contains: 192mM glycine, 19mM Tris-base and 10% 
(v/v) methanol. The solution was stored at 4°C. 
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Running buffer (5x) for SDS-PAGE contains: 192mM glycine, 25mM Tris-base and 10% (v/v) 
methanol.  
 Growth media 2.6
GM17 (Glucose Minimal 17) medium: 37,25g of M17 Broth (Oxoid) per liter of dH2O was 
dissolved and autoclaved for 15 min.   
LB (Lysogeny broth2) medium: 10g of Tryptone, 5g of Yeast Extract and 10g of NaCl per liter 
of dH2O were dissolved and autoclaved for 20 min. 
 LA (Lysogeni Agar): 15g of Bacto Agar was added per liter of LB medium prior to 
autoclaving 
MRS medium: 52g of MRS broth (Oxoid) per liter of dH2O was dissolved and then autoclaved 
for 15 min. 
MRS-agar: 15g of Bacto Agar (Saveen Wener AB) was added per liter of MRS media prior to 
autoclaving. 
MRS-soft agar: 8g of Bacto Agar (Saveen Wener AB) was added per liter of MRS media prior 
to autoclaving. 
MRSSM (MRS Sucrose Medium): 10mM MgCl2 · 6H2O and 0.5M Sucrose were added to MRS 
medium. 
2x MRS: 104g of MRS broth (Oxoid) per liter of dH2O was dissolved and then autoclaved for 
15 min. 
SOC (Super Optimal broth with Catabolite repression) medium: 20g of Tryptone and 5g of 
Yeast Extract were dissolved per liter of dH2O. In addition, 10µM NaCl and 2.5µM KCl were 
added before the solution was autoclaved for 20 min. Afterwards 20µm Magnesium Chloride 
and 20µm glucose were added before the solution was sterile filtrated. 
                                                     
2 Nomenclature defined in postscript in article by Bertani (2004) 
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 Enzymes3 2.7
Enzyme Buffer Supplier 
DyNAzyme™ II DNA 
polymerase 
10x Optimized DyNAzyme™ 
Buffer 
Finnzymes 
HindIII Buffer 2 New England BioLabs 
Lysozyme  Sigma 
Mutanolysin  Sigma 
Phusion® polymerase 5x Phusion® Buffer Finnzymes 
T4 DNA ligase 10x Ligase Buffer New England BioLabs 
XbaI Buffer 4 New England BioLabs 
XhoI Buffer 4 and Buffer 2 New England BioLabs 
DNAse I  Qiagen 
 
 Standards 2.8
Standard Supplier 
1kb DNA Ladder Invitrogen 
Prestained Protein Marker, Broad Range 
#P7708S 
New England BioLabs 
Prestained Protein Marker, Broad Range 
#P7702S 
New England BioLabs 
 
 Synthetic Peptides4 2.9
Name Sequence Reference 
PLNC8α DLTTKLWSSWGY YLGKKARWNL KHPYVQF Maldonado et al. 
(2003) PLNC8β SVPTSVYTL GIKILWSAYK HRKTIEKSFN KGFYH 
PlnJ51-Orf3 SNNKFWTWAGYTYENWRISSRRAFNLRQRKNTMTHH Navarro et al. (2008) PlnJ51-Orf4 IWQWIVGGLGFLAGDAWSHSDQISSGIKKRKKKGYGY 
PlnJ GAWKNFWSSLRKGFYDGEAGRAIRR 
Anderssen et al. (1998) PlnK RRSKRNGIGYAIGYAFGAVERAVLGGSRDYNK PlnE FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR 
PlnF VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHGs 
 
 
                                                     
3 Nomenclature as defined by Roberts et al. (2003) 
4 All peptides were ordered from Genscript with a purity of >90% 
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3 Methods 
 Cultivation and storage of bacterial strains 3.1
 Cultivation of bacterial strains 3.1.1
Lactobacilli, leuconostocs and pediococci were grown in MRS medium at temperatures at 
30°C or 37°C without shaking. Erythromycin resistant (emr) strains were grown with 10µg/ml 
or 5µg/ml erythromycin in the medium. 
E. coli DH5α® strains were grown in LB medium at 37°C. Liquid cultures were grown with 
moderate shaking (250rpm). Emr strains were grown with 300µg/ml erythromycin in the 
medium. 
Lactococcus lactis strains were grown in GM17 medium at 30°C. Emr strains were grown with 
10µg/ml erythromycin in the medium.  
 Storage of bacterial strains 3.1.2
All bacterial strains were stored in 15% (v/v) glycerol stocks. The stocks were prepared by 
adding sterile glycerol to a final concentration of 15% (v/v) to overnight bacterial culture in a 
cryo tube (Nalgene), and then stored at -80°C. Glycerol was added to prevent cell bursting 
when storing samples at -80°C. 
 Ammonium sulfate precipitation 3.2
As the sakacin 23K bacteriocin was not obtained as synthetic peptides, the α- and β-peptides 
were extracted from the two producing strains L. sakei MK 326 and L. sakei MK 327 
respectively (Kjos et al. 2010b).  The bacteriocin pediocin PA-1 was obtained using the same 
method from Pediococcus acidilactici (Nieto Lozano et al. 1992). 
1. 100ml cultures were grown overnight and then centrifuged at 7000 × g for 10 min. 
2. The supernatants were then removed and cooled at 4°C, and 30g of ammonium 
sulfate was then added to each solution. 
3. The solutions were then incubated at 4°C for 45 min with moderate shaking. 
4. Afterwards the solutions were centrifuged at 20 000 × g for 30 min. at 4°C. 
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5. The supernatants were then decanted and the pellets were dissolved in 2ml dH2O for 
a final concentration of 50x.  
6. The solutions were then incubated for 10 min at 70°C to kill any remaining bacterial 
cells.  
7. The peptide concentrates were then stored at -20°C. 
 Soft agar assay 3.3
Soft agar assays were carried out to qualitatively assay the bacteriocin sensitivity among 
different strains. All assays were carried out by diluting ON cultures approximately 100-fold 
in MRS soft agar (30µl of ON culture in 4ml of MRS soft agar) and immediately plate out the 
solution on MRS agar plates. After air drying the plates for a minimum of 5 min, 1-2 µl of 
each bacteriocin (in a 1:1 ratio of each peptide when combined5) were spotted. A spot with 
dH2O was used as a control. The plates were then incubated at 30°C or 37°C over night. The 
next day the plates were taken out of the incubator and the diameter of any zones of 
inhibition was measured. 
 Wild-type soft agar assays 3.3.1
Soft agar assays of wild-type strains were performed in order to screen for sensitive strains 
and to establish an initial degree of sensitivity. Assays were prepared as described in section 
3.3 above with 2µl of each bacteriocin spotted on. 
 Soft agar assays of transformed cells 3.3.2
Soft agar assays were performed on transformed cells in order to investigate if sensitivity to 
the complementary bacteriocin was changed. Assays were prepared as in section 3.3 above 
with the addition of 10µg/ml or 5µg/ml erythromycin in both the MRS soft agar and the MRS 
plates, with 2µl of 10-fold dilutions of NC8 and J51 bacteriocins spotted on. 
 Soft agar assays of transformed cells in presence of DTT 3.3.3
Transformed cells with FLAG™plNC8c where grown in the presence of DTT in order to 
investigate if expression of the immunity gene would be changed. The soft agar assays were 
performed as described by Cesselin et al. (2009). Different concentrations of DTT were 
added to the soft agar of each plate along with 10µg/ml erythromycin and immediately 
                                                     
5 The usage of a 1:1 peptide ratio is discussed in section 5.1. 
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plated out on MRS plates containing 10µg/ml erythromycin. Bacteriocins were spotted on as 
in section 3.3 with pediocin PA-1 as a control. All plates were incubated anaerobically at 
30°C. 
 Microtiter plate assays 3.4
A microtiter plate assay was performed on both wild type and transformant clones in order 
to quantify the sensitivity. This was done using a microtiter plate. All of the applied 
bacteriocins were mixed in a 1:1 ratio. 
ON cultures of indicator strains were diluted 50- to 100-fold in MRS medium. 150µl of these 
dilutions were added to 2-fold dilution series of each bacteriocin (diluted in a total of 50µl 
MRS medium). Wells without bacteriocin were used as growth controls, and wells containing 
only MRS medium were used as negative controls. The plates were incubated at 30°C or 
37°C until the growth in positive control wells had reached an OD620 of 0.3-0.5. The plates 
were shaken at 960 rpm for 10 sec. before reading to compensate for any uneven 
distribution of cells within the wells. 
 Wild type microtiter plate assays 3.4.1
Strains who displayed sensitivity to either PLNC8 or the putative plantaricin J51 were 
selected for microtiter plate assaying in order to quantify the sensitivity. Both PLNC8 and the 
putative plantaricin J51 were used, along with PlnJK and sakacin 23K. The MIC assay was 
carried out as in section 3.4. 
 Microtiter plate assays of transformant clones 3.4.2
Strains that had been transformed with the putative plNC8c or J51-Orf5 bacteriocin 
immunity genes were set up for microtiter plate assaying in order to quantify the sensitivity. 
Both plantaricin NC8 and the putative plantaricin J51 was used (regardless of cloned putative 
immunity gene), along with plantaricin JK. The microtiter plate assay was carried out as in 
section 3.4 with 10µg/ml or 5µg/ml erythromycin in the MRS medium. 
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 Isolation and purification of genomic DNA and plasmids 3.5
There are several ways to extract and purify DNA from bacterial cells. The choices of lysis 
and purification techniques are dependent on a number of factors. The cell wall (Gram-
positive or Gram- negative) type of DNA (genomic or plasmid) and downstream application 
of the DNA (screening, cloning etc.) are all factors which must be taken into consideration 
when determining a strategy for lysis and DNA purification.  
Commercially available kits were used to extract plasmid DNA from bacterial cells. Since 
these kits are optimized for E. coli (which is a Gram-negative bacteria (Krieg & Holt 1984)), 
some modifications were made in order to obtain sufficient amounts of plasmid DNA from 
lactobacilli. 
Two different plasmid preparation methods were applied: MIDIprep and miniprep. The 
methods differ in the amount and purity of the DNA eluate. While MIDIprep gives a larger 
amount of plasmid DNA, it also requires a larger volume of bacterial culture from which the 
DNA should be isolated from. The DNA is also precipitated during MIDIprep, which frees the 
DNA of other polluting agents. Therefore the MIDIprep method was chosen when large 
amounts of high quality plasmid DNA were needed for subsequent cloning applications. 
When the high fidelity of the MIDIprep technique was not needed (such as in PCR for colony 
screening), the less time consuming miniprep method was chosen.  
 Isolation of genomic DNA 3.5.1
Genomic DNA was isolated from Lactobacillus plantarum NC8 using a mechanical lysis 
method called Fastprep. This method involves subjecting the cells to a powerful shear force 
by shaking them in the presence of different sized glass beads. The beads will penetrate and 
fragment the cell wall and membrane of bacterial cells. As the beads will also fragment the 
chromosomal DNA, a kit for isolating plasmids can be employed to further purify the total 
genomic DNA lysate. 
1. L. plantarum NC8 was grown according to section 3.1.1 and harvested by 
centrifugation at 16 000 × g for 1 min at 4°C.  
2. The pellet was resuspended in buffer 1 from the E.Z.N.A Plasmid Minikit I and mixed 
with 0.5g of glass beads (≤106µm) in a 2ml FastPrep tube.  
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3. The tube was shaken twice at 4m/s for 20 sec in a Fastprep machine and then 
centrifuged at 16 000 × g for 2 min at 4°C (to spin down beads and unwanted cell 
debris).  
4. The supernatant was then collected and the remaining pellet was again resuspended 
in buffer 1 and step 3 was repeated two more times. 
5. The E.Z.N.A Plasmid Minikit I protocol was then resumed from step 4 in the E.Z.N.A 
miniprep protocol (See Appendix 1). 
6. The concentration of DNA eluate was measured on a Nanodrop spectrophotometer, 
and 5 µl of the eluate was analyzed on an agarose gel according to section 3.7. 
 Isolation of plasmids for cloning and sequencing (MIDIprep) 3.5.2
Plasmids where isolated from E. coli using the QIAGEN Plasmid Midi Kit according to the 
manufacturer (QIAGEN 2005). This isolation protocol exploits the slightly different 
denaturation and renaturation properties of chromosomal and plasmid DNA. Bacterial cell 
pellets were resuspended in a Tris EDTA buffer (Buffer P1) containing RNAseA (to quickly 
degrade RNA when the cells have been lysed) and lysed by addition of a NaOH-SDS solution 
(Buffer P2). A sodium acetate containing solution (Buffer P3) was added to neutralize the 
solution and to shift the solution to a high-salt binding condition. Plasmids will renature 
quickly under such conditions, while larger chromosomal DNA will aggregate and precipitate 
along with SDS-protein complexes and high molecular weight RNA. The supernatant 
containing plasmid DNA was then transferred to a silica-gel based anion-exchange column 
that readily binds DNA under high-salt conditions. Other macromolecules present in the 
supernatant will not bind to the column and was washed away using a high-salt based 
solution (Buffer QC). The DNA was eluted from the column using an isopropanol based 
buffer (Buffer QF). The DNA was further precipitated using isopropanol, then ethanol. The 
DNA pellet was then air-dried before resuspending it in dH2O. The concentration of the DNA 
was measured using a Nanodrop Spectrophotometer. 
 Isolation of plasmids for colony screening (Miniprep) 3.5.3
Plasmids from E. coli were isolated using the E.Z.N.A Plasmid Minikit I according to the 
manufacturer (Omega-bio-tek 2009). When isolating plasmids from lactobacilli some 
modifications to the manufacturers’ protocol were made. Bacterial cell pellets were washed 
with TES buffer (to remove medium and adjust pH) and resuspended in ice-cold GTE buffer 
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containing 5mg/ml Lysozyme, 15U/ml Mutanolysin and 100µg/ml RNAse A. This suspension 
was incubated at 37°C until the suspension became sticky when adding Solution 2 from the 
E.Z.N.A Plasmid Minikit I (indication of cell lysis, usually 10-50 min). The E.Z.N.A Plasmid 
Minikit I Spin Protocol was then resumed from Step 4 (See Appendix 1). This protocol follows 
the same trend as the MIDIprep protocol (section 3.5.2). The cell suspension is lysed using a 
NaOH-SDS solution (Solution II) and a sodium acetate solution is added to neutralize the 
solution again and shift the solution to a high-salt binding condition. Plasmid and highly 
fragmented chromosomal DNA will renature under these conditions, and large chromosomal 
DNA and proteins will precipitate. The supernatant (containing plasmid DNA) was then 
transferred to a silica-gel based column that readily binds the DNA, leaving other 
macromolecules prone to elution with a wash buffer (Buffer HE). The DNA was then washed 
using an ethanol based solution (DNA Wash Buffer). The DNA was eluted using the included 
elution buffer and the concentration and quality were measured using a Nanodrop 
spectrophotometer. 
 Polymerase Chain Reaction (PCR) 3.6
PCR is a basic and widely used technique in molecular biology (Sambrook & Russel 2001a). 
As such, there are many different variations of this technique, but most of them are used to 
amplify fragments of DNA. Typical components of a PCR are: a template (usually DNA), a pair 
of oligonucleotide primers, a thermostable DNA polymerase and dNTPs. The reaction is 
carried out in cycles of different temperatures to promote different activities. A cycle 
typically starts with (i) denaturing of the dsDNA at high temperature, (ii) annealing of the 
primers to the denatured ssDNA strands at a lower temperature, and (iii) extension of 
complementary DNA from the primers catalyzed by the thermostable DNA polymerase at its 
optimum temperature. Each step in the cycle is fine tuned for each application, as is the 
amount of total cycles.  
The choice of DNA polymerase was dependent on the downstream application of the 
amplified DNA fragments. When maximum fidelity was required, such as in cloning, an 
enzyme with good processivity and proofreading capabilities like the Phusion® DNA 
polymerase was used. In less sensitive applications, like in colony screening, a more basic 
(and cheaper) DNA polymerase could be utilized. The DyNAzyme™ II DNA polymerase, which 
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lacks the 3’  5’ proofreading capability of the Phusion® enzyme, was used for colony 
screening.  
 PCR for amplification of plNC8c 3.6.1
Genomic DNA containing the putative plNC8c bacteriocin immunity gene was isolated from 
Lactobacillus plantarum NC8 according to section 3.5.1. 
Two different 50µl reactions were set up using the Phusion® DNA polymerase (Finnzymes) 
system and the manufactures instructions as guidelines. One reaction was set up with 
mk303 as the forward primer, and the other reaction with the mk304 forward primer. The 
reverse primer mk305 was used in both reactions. The primers each contain a restriction site 
as an overhang used in the subsequent cloning procedure; mk305 contains an XhoI site, 
mk303 contains an XbaI site, while mk304 contains a HindIII site. For the primer sequences 
see Table 3.8. 
The PCR mixtures were set up as described in Table 3.1 below. 
Table 3.1 PCR-mixture of plNC8c gDNA. 
Solution Volume (µl) 
5x buffer 10 
Forward-primer (100µM) 0.5 
Reverse-primer (100µM) 0.5 
dNTPs (10µM of each nucleotide) 1 
Phusion® DNA Polymerase (2U/µl) 0.5 
Template gDNA (477ng/µl) 0.5 
dH2O 37 
Total 50 
 
The reactions where performed in a thermocycler following the program in Table 3.2 below 
Table 3.2 PCR-program for plNC8c amplification. 
Step Temperature (°C) Time  
1 95 5 min Initial denaturing 
2 95 30 sec Denaturing 
3 60 30 sec Annealing 
4 72 30 sec Extension 
5 30 cycles of step 2-4 
6 72 7 min Final extension 
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5µl of the PCR products were then analyzed on an agarose gel with a 1kb ladder for size 
comparison according to section 3.7. 
 Touchdown PCR for amplification of J51-Orf5 3.6.2
Genomic DNA containing J51 immunity gene was obtained as a pellet from Professor 
Carmen Torres, Universidad de La Rioja, Spain. This DNA pellet was dissolved in dH2O and 
the concentration was measured with a Nanodrop spectrophotometer. 
Reaction mixtures of 50µl were set up using the Phusion® DNA polymerase system. Two 
different reactions were set up; one with mk320 as the forward primer, and the other with 
mk321 as the forward primer. mk322 was used as reverse primer in both reactions. The 
mk322 primer contains an XhoI restriction site as overhang, while mk320 contains an XbaI 
site and mk321 a HindIII site used in the subsequent cloning. For the primer sequences see 
Table 3.8.  
Since a strong primer-dimer band was present in the agarose gels after running the same 
protocol as for the plNC8c PCR amplification, a different approach was taken. 
A so called touchdown PCR was implemented with some modifications (R.H.Don et al. 1991). 
This type of PCR is useful for optimizing reactions with unknown annealing temperatures, or 
otherwise complex or difficult PCRs. This technique is less time consuming than having to 
empirically determine the source(s) of error(s) for each reaction. Touchdown PCR takes 
advantage of the exponential feature of the PCR.  The annealing temperature is usually set a 
few degrees higher than the calculated Tm (calculated Tm for the primers were 60°C), and 
then lowered some degrees after 5 cycles until a “touchdown” of 55°C when 30 cycles are 
carried out. This will greatly increase the advantage towards the specific product. See Table 
3.4 below for a description of the program used on the thermocycler.  
A Q-solution (Qiagen) was also added to the PCR mixture in order to increase the amount of 
DNA output. The reactions were set up according to Table 3.3 below. 
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Table 3.3 PCR mixture for J51-Orf5 gDNA. 
Solution Volume (µl) 
5x buffer 10 
Q-solution 0.5 
Forward-primer (100µM) 0.5 
Reverse-primer (100µM) 0.5 
dNTPs (10µM of each nucleotide) 1 
Phusion® DNA Polymerase (2U/µl) 0.5 
Template gDNA (40ng/µl) 0.5 
dH2O 36.5 
Total 50 
 
The reactions were performed in a thermocycler following the program in Table 3.4 below 
Table 3.4 PCR-program for J51-Orf5 amplification. 
Step Temperature (°C) Time  
1 95 5 min Initial denaturing 
2 95 30 sec Denaturing 
3 62 30 sec Annealing 
4 72 30 sec Extension 
5 5 cycles of step 2-4 
6 95 30 sec Denaturing 
7 58 30 sec Annealing 
8 72 30 sec Extension 
9 5 cycles of step 6-8 
10 95 30 sec Denaturing 
11 55 30 sec Annealing 
12 72 30 sec Extension 
13 30 cycles of step 9-11 
14 72 7 min Final extension 
 
5µl of the PCR products were then analyzed on an agarose gel with a 1kb ladder for size 
comparison according to section 3.7. 
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 PCR for colony screening 3.6.3
After cloning and transformation, a simple PCR test was used to check if any transformed E. 
coli or lactobacilli contained the desired insert. If the desired insert was present in cells from 
tested colonies, this insert would be amplified by PCR and produce a strong band when 
subjected to an agarose gel electrophoresis.  
Plasmids were isolated according to section 3.5.3 and the DNA concentration of the eluate 
was measured using a Nanodrop spectrophotometer. The same primer pairs as in the initial 
amplification were used (i.e. mk303 and mk305 or mk304 and mk305 for the plNC8c 
constructs, and mk320 and mk322 or mk321 and mk322 for the J51-Orf5 constructs. The 
reactions were set up according to Table 3.5 below.  
Table 3.5 PCR-mixture of plasmid DNA for colony screening. 
Solution1 Volume (µl) 
10x DyNAzyme™ buffer 2 
Forward-primer (10µM) 1 
Reverse-primer (10µM) 1 
dNTPs (10µM of each nucleotide) 0.5 
DyNAzyme™ II polymerase (2U/µl) 0.2 
Template plasmid DNA (approximately 100ng) 2 - 12 
dH2O 3.3 -13.3 
Total 20 
1 0.5 µl solution Q was added to the reaction for screening of J51 clones. 
The reactions where performed in a thermocycler following the program in Table 3.6 for the 
plNC8c clones and Table 3.7 (Touchdown PCR) for the J51-Orf5 clones. 
Table 3.6 PCR program for plNC8c colony screening. 
Step Temperature (°C) Time  
1 95 5 min Initial denaturing 
2 95 30 sec Denaturing 
3 60 30 sec Annealing 
4 72 45 sec Extension 
5 30 cycles of step 2-4 
6 72 7 min Final extension 
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Table 3.7 PCR-program for J51-Orf5 colony screening. 
Step Temperature (°C) Time  
1 95 5 min Initial denaturing 
2 95 30 sec Denaturing 
3 62 30 sec Annealing 
4 72 45 sec Extension 
5 5 cycles of step 2-4 
6 95 30 sec Denaturing 
7 58 30 sec Annealing 
8 72 45 sec Extension 
9 5 cycles of step 6-8 
10 95 30 sec Denaturing 
11 55 30 sec Annealing 
12 72 45 sec Extension 
13 30 cycles of step 9-11 
14 72 7 min Final extension 
 
10µl of the PCR products were then analyzed on an agarose gel with a 1kb ladder for size 
comparison according to section 3.7. 
 
Table 3.8 PCR primers. 
Name Sequence (5’ 3’)1 Complementing 
restriction enzyme 
mk303 ACGTTCTAGAAGTTATGGAGCTCTTGGGGA XbaI 
mk304 ACGTAAGCTTATGGAGCTCTTGGGGATATTA HindIII 
mk305 ACGTCTCGAGATCGATTCTATGAATAAACCGG XhoI 
mk320 ACGTTCTAGATTTGTTCTTTTAATGTTTCGGGT XbaI 
mk321 ACGTAAGCTTATGTTTCGGGTAGATAAAGACA HindIII 
mk322 ACGTCTCGAGATAAACTCTCATTAGTGCTGCA XhoI 
1 Restriction sites are underlined 
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 Agarose gel electrophoresis 3.7
Agarose gel electrophoresis was used to inspect and separate DNA. Agarose forms a network 
of pores in the gel-state which allows for a separation of the negatively charged DNA 
fragments by size when an electric current is applied. Smaller fragments will migrate more 
easily than larger ones through the pores. The fluorescent dye and intercalating agent 
ethidium bromide was added to 1% (w/v) TAE-agarose gels and DNA samples were mixed 
with loading buffer prior to application. An electric current of approximately 75V was 
applied during the electrophoresis of the gels. The fragments were visualized under ultra 
violet light (λ = 312nm). 
 Plasmid construction 3.8
The pMG36e plasmid was used as an expression vector (Guchte et al. 1989). This plasmid 
contains an erythromycin resistance gene (ermC) useful for selection of cells containing the 
plasmid. It also has another functional gene, repA which governs the replication of the 
plasmid. The multiple cloning site (MCS) is located downstream  of a constituently active 
promoter called P32 which will lead to any insert being transcribed at a relative high level 
(Venema 1993). 
When constructing plasmids with plNC8c and J51-Orf5 genes, a derivate of the pMG36e 
plasmid called p363 was used (Diep et al. 2007). The p363 contains the flciA gene inserted in 
the MCS of pMG36e. This gene has a so called FLAG™ encoding sequence just downstream 
of the promoter area. The FLAG™ sequence (MDYKDDDDK) is a highly hydrophilic sequence 
stretch that will usually not fold into the protein (Hopp et al. 1988). This sequence will be 
fused to the N-terminal of the translated gene resulting in a tag that makes it possible to 
detect and purify the protein. By using restriction enzymes which cuts either upstream or 
downstream of the FLAG™ sequence, one can easily construct plNC8c and J51-Orf5 genes 
both with and without a FLAG™-tag in their respective translated products.  
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Figure 3.1 Overview of the p363 plasmid, a pMG36e derivate (Guchte et al. 1989). Genes are 
indicated in green with arrows showing direction of transcription. Restriction sites are shown as 
hourglass figures. 
Before the genes can be inserted into the plasmids, the plasmids need to be cut open, so the 
inserts have free ends to ligate to. This is done by using restriction enzymes that cleave the 
plasmid and linearize it. These restriction enzymes do not cut the dsDNA vertically, but 
rather generate a so called “sticky end” with an overhang at the opposite strand at each 
fragment (see example in Figure 3.). This overhang also reduces the possibility for the 
plasmid to religate to itself after being cut. Since the p363 plasmid already had an insert 
between the two restriction sites, a smaller band should appear when subjecting the 
restriction reaction to an agarose gel electrophoresis. This would serve as a control that the 
plasmids had been cut correctly. 
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3.1.1 PCR cleanup 
Before initiation of the restriction reaction, the PCR products need to be free of pollutants 
that can disturb the restriction reaction. The PCR solutions from section 3.6.1 and 3.6.2 were 
purified using the Macherey-Nagel Nucleospin® Extract II kit according to the manufacturer 
(Macherey-Nagel 2010). This protocol is based on purifying DNA on a silica membrane based 
column, which adsorbs DNA under high salt conditions, leaving contaminants like salts and 
soluble macromolecular complexes vulnerable to elution. Two volumes of Buffer NT were 
added per 1 volume of PCR solution, and the mixed solution was loaded on NucleoSpin® 
Extract II Column.  An ethanol based buffer (Buffer NT3) was added to elute contaminants. 
DNA was eluted by addition of a slightly alkaline buffer (Buffer NE) and the DNA 
concentration of the eluate was measured using a Nanodrop spectrophotometer. 
 Restriction reactions 3.8.1
A total of eight restriction reactions were set up, four with the plasmid vectors and four with 
the inserts according to Table 3.9 below. 
Table 3.9 Restriction reactions. 
 plNC8c restriction reactions J51-Orf5 restriction reactions 
 Wild type gene With FLAG™- tag Wild type gene With FLAG™- tag 
 Vector Insert Vector Insert Vector Insert Vector Insert 
DNA 3µl 
(625ng/
µl) 
9µl 
(132ng/
µl) 
3µl 
(625ng/
µl) 
9µl 
(164ng/
µl) 
3µl 
(625ng/
µl) 
14µl 
(40ng/
µl) 
3µl 
(625ng/
µl) 
14 µl 
(43ng/
µl) 
10x 
buffer 
Buffer 4 (2µl) Buffer 2 (2µl) Buffer 4 (2µl) Buffer 2 (2µl) 
BSA 2µl (1mg/ml) 
Enzy
me 1 
1µl XbaI (20U/µl) 1µl HindIII (20U/µl) 1µl XbaI (20U/µl) 1µl HindIII(20U/µl) 
Enzy
me 2 
1µl XhoI (20U/µl) 
dH2O 11µl 5µl 11µl 5µl 11µl 0 µl 11µl 0 µl 
Total 20 µl 
 
Figure 3.2 Cutting example of the restriction 
enzyme HindIII with the recognition site marked in 
red, and actual cut by full lines (Old et al. 1975) 
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The reactions were incubated in a water bath at 37°C for 2h. After 1h, 1µl of CIP (Calf 
Intestinal alkaline Phosphatase) and 2µl of Buffer 3 was added to each of the vector 
reactions. This was done to prevent self-religation of the vector. 
The whole volumes of the reactions were analyzed in an agarose gel as described in section 
3.7. The visualized bands were then cut out of the gel and the mass was measured using a 
balance.  
 Gel clean up 3.8.2
As the samples from section 3.8.1 contained heavy amounts of agarose and ethidium 
bromide that would hinder subsequent ligation reactions, these contaminants needed to be 
removed. This was done using the same kit as described in section 3.1.1, as this kit is also 
designed to purify DNA from agarose gels. In order to dissolve the agarose, 200µl Buffer NT 
per 100mg of gel was added, and the samples were heated at 50°C for 5-10min and vortexed 
every 2-3min until the gel was completely dissolved. The rest of the procedure is identical as 
the one described in section 3.1.1. The concentrations of the eluted DNA samples were 
measured using a Nanodrop spectrophotometer.  
 Ligation and drop-dialysis 3.8.3
The inserts and vectors were now ready to be ligated using an enzyme which fuses two DNA 
fragments by making a covalent bond between the 3’ hydroxyl ends of one nucleotide, with 
the 5’ phosphate end of another nucleotide (Sambrook & Russel 2001b). The T4 DNA ligase 
(isolated from bacteriophage T4, New England Biolabs) was used in this study. As plasmids 
without inserts are unwanted, a molar ratio of 1:5 of plasmid versus insert was chosen to 
maximize insertion of inserts into plasmids. Four reactions were set up according to Table 
3.10 below. 
Table 3.10 Ligation reaction mixes. 
 plNC8c J51-Orf5 
Constructs Wildtype FLAG™-tag Wildtype FLAG™-tag 
Insert 4µl (23ng/µl) 4µl (11ng/µl) 6µl (21ng/µl) 6µl (22ng/µl) 
Vector 1µl (55g/µl) 1µl (29ng/µl) 2µl (39ng/µl) 2µl (31ng/µl) 
Buffer 2µl T4 DNA ligase buffer 
Ligase 1µl T4 DNA ligase (400U/µl) 
dH2O 12µl 9µl 
Total 20µl 
  3. Methods 
36 
 
The solutions were incubated on a thermocycler programmed to run at 16°C for 16h, then 
65°C for 20min (to deactivate the ligase). 
As any salts present in the ligation mixes may cause an overflow of electricity and kill cells or 
even destroy equipment during electroporation, it is important to remove salts after ligation. 
This was done by drop dialysis. The samples were spotted on a filter with 0.025µm pores, 
floating on top of 0.1x TE-buffer and incubated for at least 1h.  
 Preparation and transformation of cells 3.9
As direct transformation of ligation reactions into lactobacilli is very difficult, E. coli DH5α® 
cells were chosen as intermediate hosts. E. coli DH5α® have a much higher transformation 
rate than lactobacilli, and the generation time is shorter, ensuring that more plasmids can be 
harvested from the same volume of culture (Aukrust et al. 1995; Tortora et al. 2007). 
There are several different transformation methods for the transformation of bacteria, but 
most of them work by the same principle of weakening the cell envelope, and thereby 
allowing the influx of foreign DNA (Sambrook & Russel 2001b). Transformation by 
electroporation works by subjecting the cells to an electrical pulse of high voltage (over one 
thousand Volts) in a suspension of DNA, which creates water filled pores in the membrane 
big enough to let the foreign DNA (which is negatively charged) pass into the cells (Neumann 
et al. 1982). Before the cells can be transformed, they need to be prepared for 
electroporation by removing extracellular polysaccharides and weaken the cell wall. 
Electroporation was chosen as the method of transformation for both E. coli and 
Lactobacillus although the protocols differ slightly from each other. 
 Preparation of electro competent E. coli DH5α® cells 3.9.1
E. coli DH5α® cells were prepared according to Ausbel (1995) with some minor 
modifications. 
1. 100ml of LB medium was inoculated with 1ml ON culture of E. coli DH5α ®cells 
and grown according to section 3.1.1 to an OD600 of 0.4 – 0.5. 
2. The culture was then chilled on ice for 30 min. 
3. Cells where then harvested by centrifuging for 10 min at 7000 × g at 4°C and the                                                                                                                                
supernatant was removed.  
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4. The pellet was washed four times with 50ml of ice-cold 10% (v/v) glycerol solution. 
5. The final cell pellet was then resuspended in in ice-cold GYT medium to a final  
volume of 500µl. 
 
Cells where either transformed immediately according to section 3.9.2, or stored in smaller 
aliquots at -80°C. 
 Transformation of ligation mixes in electrocompetent E. coli DH5α® 3.9.2
Ligation mixes from section 3.8.3 were transformed into E. coli DH5α® cells according to 
Ausbel (1995). 
1. 20µl of electrocompetent cells (from section 3.9.1) was transferred to an ice-cold  
1mm cuvette placed in the electroporation apparatus. 
2. The electric pulse was delivered with the following settings: voltage 1.7kV, resistance  
200 Ω, and capacitance 25µF. 
3. 1ml of ice-cold SOC medium was added immediately to the cuvette after  
electroporation. 
4. The cells where resuspended and transferred to eppendorf tubes and incubated at  
37°C for 1h with moderate shaking. 
5. 100µl and 200µl aliquots where then plated out on LA plates containing 300µg/ml  
erythromycin and grown according to section 3.1.1 for one to two days. A 10-5 fold  
dilution plated out on medium not containing antibiotics was used as a  
transformation efficiency control. 
At least five colonies from each construct where picked with a sterile toothpick and placed in 
5ml of LB medium with 300µg/ml of erythromycin and grown ON. Plasmids where then 
isolated from each of the colonies according to section 3.5.3 and checked for inserts using 
PCR screening as in section 3.6.3. Colonies revealed to have a positive PCR product where 
stored as in section 3.1.2 and a high-yield plasmid isolation was performed according to 
section 3.5.2. The isolated plasmids were checked for correct insert by sequencing as in 
section 3.10. 
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 Preparation of electro competent Lactobacillus cells 3.9.3
Lactobacillus strains sensitive for bacteriocins NC8 and J51 where prepared for 
electroporation according to (Aukrust et al. 1995). These cells where transformed with 
plasmids containing plNC8c or J51-Orf5 isolated from E. coli for heterologous expression of 
the respective genes. A glycine gradient was used to find the highest glycine concentration 
which still allowed optimal growth of cells. 
1. 5ml of culture was grown ON and reinnoculated in 5ml cultures containing 1%, 1.3%,  
1.5%, 1.8%, 2% and 2.5% (v/v) glycine in MRS medium and grown ON. 
2. Cells where then diluted to an OD600 of 0.1 in 50ml MRS cultures containing 1%, 1.5%  
and 2% (v/v) glycine and grown to an OD600 of 0.4. 
3. Cells where then harvested by centrifugation at 3000 × g at 4°C for 10 min. 
4. The supernatant was then removed, and cells were washed with 12.5 ml of ice-cold  
TES buffer and centrifuged as in step 3 above. 
5. The supernatant was then discarded and the pellet was washed with 50ml of 1mM  
MgCl2 and centrifuged as in step 3 above. 
6. The supernatant was then removed and the pellet was washed in 25ml of 30% (w/v)  
PEG1500 and centrifuged at 6000 × g at 4°C for 10 min. 
7. The supernatant was then removed and the pellet was resuspended in 500µl of 30%  
(w/v) PEG1500.  
Cells where either transformed immediately according to section 3.9.4, or stored in smaller 
aliquots at -80°C. 
 Transformation of plasmids in bacteriocin sensitive lactobacilli 3.9.4
Plasmids isolated from E. coli were transformed in lactobacilli. The pMG36e plasmid isolated 
without insert from E. coli DH5α® pMG36e was used as a control. Lactobacilli where 
transformed according to Aukrust et al. (1995). 
1.  5µl of plasmid DNA was added to 40µl of competent cell suspension (from section  
3.9.3) and mixed gently. 
2. The solution was then transferred to an ice-cold 2mm cuvette placed in the  
electroporation apparatus 
3. The electric pulse was delivered with the following settings: voltage 1.5kV, resistance  
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400 Ω and capacitance. 
4. 960µl of ice-cold MRSSM medium was added immediately to the cuvettes after  
electroporation.  
5. The cells where resuspended and transferred to culture tubes and incubated at 30°C  
for 4h. 
6. 250µl and 755µl aliquots where plated out on MRS agar plates and grown according  
to section 3.1.1 for one to three days. 
 
At least five colonies from each construct where picked with a sterile toothpick and placed in 
5ml of MRS medium with 10µg/ml or 5µg/ml of erythromycin and grown ON. Plasmids 
where then isolated from each of the colonies according to section 3.5.3 and checked for 
inserts using PCR screening as in section 3.6.3. Colonies revealed to have a positive PCR 
product where stored as in section 3.1.2. 
 DNA sequencing 3.10
Plasmids isolated from transformed E. coli DH5α® cells where double checked for insert 
using DNA sequencing. This was done using a variant of the so called chain-terminating 
method (Sanger et al. 1977). A PCR like reaction was set up with only one primer for each 
reaction (forward or reverse) with fluorescently labeled dideoxynucleotides (ddNTPs) in 
shortage (compared to unlabeled dideoxynucleotides). This will terminate the elongation 
whenever a dideoxynucleotide is incorporated into the DNA fragment by the polymerase. 
Each 3’ end of the newly synthesized strand will therefore be fluorescently labeled. Different 
labels are used for different ddNTPs and since there is only one primer for each reaction, 
fragments of different sizes will be produced. These fragments will migrate through a gel-
filled capillary tube based on size (same principle as agarose gel electrophoresis explained in 
section 3.7). The fragments can then be read by a laser at the end of the tube which 
determines the sequence of the DNA sample based on the incorporated fluorescent dye 
(Swerdlow & Gesteland 1990). 
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 DNA sequencing reaction 3.10.1
The DNA sequencing reaction is in principle much the same as the PCR with minor 
differences explained in section 3.10 above. Two reactions were set up for each clone 
already displaying a positive PCR product when checked for insert (as in section 3.6.3).One 
reaction was set up using the forward primer, and one with the reverse. Each reaction was 
set up according to Table 3.11 with one of the corresponding primers from Table 3.8. 
Table 3.11 DNA sequencing reaction mixes. 
Solutions Volume (µl) 
Premix 2 
Sequencing buffer 3 
Primer (1µM) 3.2 
Plasmid DNA (approximately 200ng) 0.5 - 2 
dH2O 11.3 - 9.8 
Total 20 
 
The reactions were performed on a thermocycler following the program in Table 3.12 below. 
Table 3.12 Sequencing reaction program. 
Step Temperature (°C) Time  
1 96 1 min Initial denaturing 
2 95 10 sec Denaturing 
3 50 5 sec Annealing 
4 60 4 min Extension 
5 25 cycles of step 2-4 
 
The reactions where then precipitated as describes in section 3.10.2 below. 
 Precipitation of DNA sequencing reaction products 3.10.2
Before the reactions can be read, they need to be free of pollutants like primers and unused 
fluorescent ddNTPs which can disturb the reading of the sequence by the laser. The principle 
behind this DNA precipitation method is much the same as the principle behind the 
precipitation in MIDIprep (see section 3.5.2). 
1. 2µl of 125mM EDTA was added to each of the 20µl sequence reactions along with 2µl  
of 3M Sodium Acetate. The solutions where then transferred from the PCR tubes to  
1.5ml Eppendorf tubes. 
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2. 52µl of 96% (v/v) ethanol was then added to each tube and mixed by invertion 5  
times. 
3. The solutions were then incubated for 15 min at room temperature. 
4. The tubes were then centrifuged at 16 000 × g for 30 min at 4°C. 
5. The supernatant was then discarded and 70µl of 70% (v/v) Ethanol was then added to  
each tube for washing. 
6. Tubes were then centrifuged at 16 000 × g for 10 min. 
7. The supernatant was then discarded and the pellet was dried under a desk lamp for  
5-10 min and then stored at -20°C.  
 
The pellets where dissolved and applied to the ABI Prism 377 DNA Sequencer and read by 
the machine.6 The chromatograms were curated using the BioEdit software by removing 
poor sequence regions in the ends (Hall 1999). Each complementary forward and reverse 
sequence were combined using the CAP Contig Assembly Program within the BioEdit 
software suite (Huang 1992). The assembled contigs were aligned with their respective 
reference sequences using the sequence alignment feature of the blastn software hosted on 
NCBIs webpage (Zhang et al. 2000). 
 Cell lysis and protein purification 3.11
In order to study protein expression in the transformed Lactobacillus strains, the protein 
contents of the cells needs to be extracted. Several techniques exist, among them are 
FastPrep (a modification of the protocol described in section 3.5.1) and French press, which 
is more suited for large scale protein extraction. The French press method also employs a 
mechanical lysis strategy, but by the way of subjecting cells to a sudden pressure drop from 
31 026 kPa to 100 kPa causing the cells to burst open, releasing the protein content.  
As the subsequent immunoblotting techniques is best suitable for FLAG™-tag species of 
plNC8c7, only L. sakei transformed with FLAG™-plNC8c and L. plantarum 2-1 transformed 
with FLAG™ plNC8c were cultured. The respective strains cloned with the empty plasmid 
pMG36e was used as negative controls, and the Lactococcus lactis IL1403 strain containing a 
                                                     
6 The DNA sequencer was operated by lab-technician Zhian Salehian. 
7 No strains sensitive to J51 where able to be transformed with constructs containing FLAG™J51-Orf5 
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FLAG™-tagged flciA gene was used as a positive control (Diep et al. 2007). The flciA gene is 
roughly the same size as the FLAG™-plNC8c gene when expressed (12.3kD and 11.5kD 
respectively).  
 Fast-prep 3.11.1
The Fast-prep protocol for protein extraction is very similar to the fast-prep protocol for DNA 
extraction (as explained in section 3.5.1) although some modifications were performed, as 
the E.Z.N.A. plasmid minikit I protocol was not followed. 
1. 40ml cultures were harvested by centrifugation at 7 200 × g for 3 min at 4°C. 
2. The supernatant was then discarded and the pellet was dissolved in 1ml ice-cold TBS  
buffer and centrifuged at 16 000 × g for 1 min at 4°C. 
3. The supernatant was then discarded and the pellet was resuspended in 1ml of ice- 
cold TBS buffer and transferred to a FastPrep tube. 
4. 0.8g of glass beads (≤106µm) were added to the tubes. 
5. The tubes were shaken twice at 6m/s for 30 sec at 4°C. 
6. The tubes where then centrifuged at 16 000 × g for 2 min at 4°C. 
7. The supernatant was transferred to a separate tube and 350µl of ice-cold TBS buffer  
was added to the FastPrep tubes. 
8. The FastPrep tubes were shaken and centrifuged again as in steps 5 and 6. 
9. The supernatant was transferred to their respective tubes as in step 7 and the  
protein concentration was measured on a Nandrop spectrophotometer. 
 French-press 3.11.2
French press lysis was carried out according to Nissen-Meyer et al. (1993). 
1. A 2L culture of each strain was harvested by centrifugation at 10 600 × g for 10 min at  
4°C when OD600 was between 0.4 and 0.9. 
2. The supernatant was discarded and the pellet was resuspended in 80ml ice-cold TBS  
buffer and centrifuged at 6000 × for 10 min at 4°C. 
3. The pellet was washed again as described in step 2. 
4. Each pellet was resuspended in 40ml ice-cold TBS buffer and passed through a French  
Pressure cell at 31 026 kPa.  
5. 40µl of DNAse I (10mg/ml) was added to the suspension, and the suspension was  
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passed through the French pressure cell again at 31 026 kPa.8 
6. The suspensions where centrifuged at 6000 × g for 20 min at 4°C. 
7. The supernatant was then split into 8ml aliquots and the concentration was  
measured on a Nanodrop spectrophotometer. 
8. The aliquots where stored at -80°C 
 Protein purification by resin binding 3.11.3
The FLAG™ proteins where purified using the ANTI-FLAG™ M2 Affinity gel which contains 
ANTI-FLAG™ M2 antibodies covalently attached to agarose, and eluted using a competitive 
binding strategy by the use of 3X FLAG™ peptides (Einhauer & Jungbauer 2001).  
As the ANTI-FLAG™ M2 resin is stored in a glycerol solution, the glycerol needs to be 
removed before use. 
1. 40µl of resin solution was used for each sample. 
2. 1ml of ice-cold TBS was added to the resin solution and mixed carefully by invertion.  
The tube was centrifuged at 11 000 × g for 5 sec and incubated on ice for 2 min. 
3. The supernatant (containing glycerol) was then removed.  
4. The washing steps (step 2-3) where then repeated 3 times. 
5. The volume was then adjusted to 100µl per sample by addition of ice-cold TBS buffer 
6. 24mg of protein sample (dissolved in ice-cold TBS buffer to a total of 900µl)and 100µl  
of the resin solution from the previous step was added to each sample along with  
100µl of 10% Triton X-100 (to avoid unspecific binding to the resin).9 
7. The resin containing samples were then mixed on a rotor at 8 rpm over  
night at 4°C. 
8. The next day the resin samples were washed by centrifugation at 11 000 × g for  
5 sec and incubated on ice for 20 minutes. 
9. The supernatant was then removed and 1ml of ice-cold TBS was added. 
10. The washing steps (step 8-9) were then repeated 4 times. 
11. 3µl of 3x FLAG™-tag stock (5mg/ml) was mixed with 100µl of ice-cold TBS buffer and  
added to each resin-sample solution from the previous step. The samples were mixed  
                                                     
8 The French pressure cell was washed with water, dH2O and ice-cold TBS buffer between each different sample 
9 Different detergents at different concentrations were also tested without yielding any better results (data not 
shown) 
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on a rotor at 8 rpm for 30 min at 4°C. The tubes were flicked every 10 min. 
12. The samples were then centrifuged at 11 000 × g for 10 sec and incubated on ice for 2  
min. 
13. 100µl of the supernatant, containing the eluted proteins, was then transferred to a  
new tube and stored at -20°C. 
 SDS-PAGE, staining and Western blotting 3.12
SDS-PAGE was performed to analyze the purified protein fractions from section 3.11.3. The 
proteins were visualized using unspecific staining (Coomassie and Silver staining) or blotted 
onto a membrane for immunodetection. 
 SDS-PAGE 3.12.1
SDS-PAGE was used to separate proteins according to size. This technique is somewhat 
similar to the agarose gel electrophoresis used to separate DNA (explained in section 3.7). 
Proteins are denatured by heating prior to electrophoresis. The proteins are subjected to an 
electrical field in a gel-based mesh network containing negatively charged SDS molecules, 
which coats the protein fragments giving them an equal mass to charge ratio upon which 
proteins are separated.  
1. Samples were mixed with an equal volume of 2x SDS-Sample buffer (both with and  
without 2-merkaptoethanol where appropriate) and boiled for 3-5 min at 100°C  
before being applied to the polyacrylamide gel.  
2. SDS-PAGE was performed according to (Laemmli 1970) with a 4% stacking gel10 and a  
12% or 15% separation gel11. Prestained Protein Markers were used to determine  
relative sizes of the observable bands along with protein samples from Lactococcus  
lactis IL1403 transformed with flciA which was used as a positive control. 
3.  Electrophoresis was performed at 100V in a 1x running buffer until the sample dye  
had exited the gel. 
                                                     
10 Stacking gel contains: 4% acrylamid/bis-acrylamid (40/0.8), 0.125M Tris-HCl (pH 6.8), 0.1% (w/v) SDS, 0.05% 
(w/v) APS, 0.1% (v/v) TEMED and 0.1% (w/v) bromophenol blue 
11 Separation gel contains: 15% or 12% acrylamid/bis-acrylamid (40/0.8), 0.375M Tris-HCl (pH 8.8), 0.1% (w/v) 
SDS, 0.05% (w/v) APS and 0.05% (v/v) TEMED. 
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 Coomassie staining 3.12.2
Coomassie staining was performed to visualize proteins separated by SDS-PAGE. This dye 
binds proteins unspecifically, however the mechanisms behind the dye-protein binding is not 
well understood. 
1. The gel was submerged in a staining solution12 containing the Commassie Brilliant  
Blue G-250 dye and heated to boiling point in a microwave oven to increase the  
staining rate. The gel-solution was incubated for 30 min with moderate shaking. 
2. The gel was washed once with dH2O to remove unbound dye, and then submerged in  
a destaining solution13 and heated to boiling point in a microwave oven (to increase  
the destaining rate). The gel-solution was then incubated for 2h with moderate  
shaking with a small piece of paper tissue in the solution, to further increase the  
destaining rate. 
 Silver Staining 3.12.3
Silver staining is another method to visualize proteins in a polyacrylamide gel. The method is 
based on the binding of Ag2+-ions to amino acid side chains (Merril et al. 1981). These ions 
are then reduced, producing visible silver stained bands. The silver staining method is 10-100 
fold more sensitive than staining with coomassie brilliant blue (depending on which protocol 
is used).  
1. The proteins in the gel were fixed by submerging the gel in a 100ml solution  
containing 50% (v/v) methanol and 10% (v/v) acetic acid, which was then heated in a  
microwave oven at 800W for 1 min, before shaking at room temperature for 15 min. 
2. The solution was then exchanged with 100ml dH2O for washing. The gel-water  
solution was heated in a microwave oven at 800W for 1 min, and then shaken for 15  
in room temperature. 
3. The water was then poured off and a 100ml dH2O solution containing 5µg/ml DTT, to  
prevent reformation of disulfide bonds, was added to the gel. The gel-DTT solution  
was then heated in a microwave oven at 800W for 1 min, and then shaken at room  
temperature for 15 min. 
                                                     
12 Staining solution contains: 0.2% (w/v) Coomassie Brilliant Blue R-250, 50% (v/v) methanol and 7.5% (v/v) 
acetic acid. 
13 Destaining solution contains: 5% (v/v) methanol and 7% (v/v) acetic acid. 
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4. The solution was then removed and a dH2O solution containing 0.2% (w/v) silver  
nitrate was added, and then shaken at room temperature for 15 min. 
5. The silver nitrate solution was then removed and the gel was washed twice with  
100ml of dH2O and then twice with 50ml developer solution, which contains 0.3%  
(w/v) disodium carbonate. 
6. For development 0.037% (v/v) formaldehyde was added to 100ml developer solution,  
poured on gel and shaken until bands were clearly visible. 
7. To stop the developing reaction, 5ml of 2.3M citric acid (to a final concentration of  
110mM) was added and then shaken for an additional 10 min. 
8. The solution was then removed, and the gel was washed several times with dH2O (to  
minimize yellow background). When necessary, 100ml of 5% (v/v) glycerol was  
added for storage. 
 Western blotting 3.12.4
Western blotting was performed to specifically detect the FLAG™-tagged PLNC8c immunity 
proteins. The proteins separated by SDS-PAGE were transferred to polyvinylidene membrane 
by electro-blotting. The proteins were visualized by a series of continuous steps starting with 
the addition of ANTI-FLAG™ M2 antibodies which binds specifically to the FLAG™-tag 
containing proteins. Then a secondary antibody (which binds specifically to the first 
antibody) with the conjugated enzyme horseradish peroxidase (HRP) was added. This 
enzyme catalyzes a reaction with the ECL detection reagents resulting in chemiluminescence 
that can be visualized by exposure to a film.  
Western blotting was performed as described by Straume et al. (2006). 
1. SDS-PAGE separated proteins were electroblotted onto a polyvinylidene membrane  
using the Mini Trans-Blot System for 1h at 100V in cold transferbuffer. 
2. The membrane was then incubated in 5% (w/v) skimmed milk powder dissolved in  
PBS-T for 1h with gentle shaking to prevent unspecific binding of antibodies to the  
membrane. 
3. The membrane was washed for 10 min with 30ml PBS-T with gentle shaking before  
incubating the membrane with the primary antibody ANTI-FLAG™ M2 in PBS-T  
(1:4000) for 1h with gentle shaking. 
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4. The membrane was again washed 3 × 10 min with 30ml PBS-T with gentle shaking  
before incubating the membrane with the secondary HRP-linked antibody Anti- 
Mouse Ig in PBS-T (1:4000) for 1h with gentle shaking. 
5.  The membrane was washed again 3 × 10 min with 30ml PBS-T with gentle shaking to  
remove any unbound antibodies and the PBS-T solution was removed. 
6. 1ml of ECL Plus Solution A and 25µl of ECL Plus Solution B was mixed, brought to  
room temperature and applied on the membrane.  A film was exposed to the  
membrane for 15-20 min and developed for 10 sec in a development  
solution and fixed for 10 sec in a fixation solution. The film was washed in water  
before and after the fixation and finally air-dried. 
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4 Results 
 Bacteriocin sensitivity assays 4.1
Assays were performed on a wide variety of indicator strains in order to investigate the 
spectrum of inhibition by plantaricin NC8 and the putative plantaricin J51. Having several 
strains that are sensitive for each of the bacteriocins is also preferable when the putative 
immunity proteins are to be expressed heterologuosly, as not all strains are easily 
transformable. Soft agar assays were performed first in order to quickly screen many strains 
for sensitivity. The sensitivity of any sensitive strains was then further quantified using a 
minimum inhibitory concentration assay. 
 Soft agar assays of wild type strains 4.1.1
Soft agar assays were performed using separate peptides, and then mixed in order to 
investigate if the individual peptides showed any anti-microbial effect on their own. This was 
also done to investigate if the two complementary peptides showed synergistic activity 
when combined, which is typical for two-peptide bacteriocins. 
 
Figure 4.1 Soft agar assay of plantaricin JK (top row, 50ng of each single peptide) and plantaricin 
NC8 (middle row, 50ng of each single peptide) using Lactobacillus sakei NCDO 2714 as indicator. 
Bottom row is putative plantaricin J51 (200ng of each single peptide) using L. plantarum DSM 
20174 as indicator. 
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As the soft agar assays indicated that the peptides needed the complementary peptides for 
optimal anti-microbial effect, the rest of the screening was performed using both 
complementary peptides (in a 1:1 ratio). 
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Table 4.1 Overview of soft agar assay of indicator strains to different bacteriocins.1 
Indicator strains LMGT 
number 
PlnEF PlnJK PLNC8 Putative 
PlnJ51 
Lactobacillus acidophilus       
 NCDO 1748 2303 - - - - 
 ATCC 3456 2712 - - - - 
L. amylophilus NCDO 2503 2300 - - - - 
L. amylovorus NCDO 2657 2301 - - - - 
L. casei NCDO 2743 2324 - - ++ - 
L. cellobiosus NCDO 927 2306 - - - - 
L. coryneformis NCDO 2741 2309 - ++ - - 
L. curvatus      
 NCDO 2739 2310 - - - - 
 CTC 435 2371 - - + - 
 89 2355B + - - - 
 BCS35 3291 - - - - 
L. delbrueckii NCDO 213 2331 - - - - 
L. helveticus ATCC 15009 2761 - - - - 
L. fermentum ATCC 9338 V 2716 - - ++ + 
L. plantarum      
 965 2003 + ++ + ++ 
 R 2352 - ++ - - 
 DSM 20174 2378 - ++ - + 
 AA23 2389 - ++ - - 
 ACA-DC 289 3160 - + - - 
 2-1 3176 - - ++ - 
 2-2 3177 - - - - 
 ACA-DC 3333   3215 - + - - 
 ACA-DC 3341 3216 - - - - 
 ACA-DC 3342 3217 - - - - 
L. rhamnosus GG 3087 - - - - 
L. salivarius 83 3494 - - - - 
L. sakei      
 2F13 3147 - - - - 
 23K 3051 - - - - 
 64F 3052 - - - - 
 NCDO 2714 2313 + + ++ + 
 CTC A4 2373 - - - - 
 460 2376 - - - - 
 DSM 20017 2377 - - - - 
 706 2334 - - - - 
 45 2340 - - - - 
 77 2360 - - - - 
L. viridesence NCDO 1655 2314 - ++ - - 
Lactococcus lactis MG1363 2144 - - - - 
Leuconostoc mesenteroides Y105 3081 - - - - 
Pediococcus  pentosaceus NCDO 
990 
2315 - - - - 
1 “–“ indicates no visible sensitivity. “+ “ indicates slight inhibition with diffuse zones up to 5mm in diameter. 
“++”  indicates inhibition with clear zones up to 6mm in diameter. 
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Only a few strains showed sensitivity to the bacteriocins plantaricin NC8 and the putative 
plantaricin J51. The sensitivity of these strains was then further characterized using a 
mictrotiter plate assay to determine minimum inhibitory concentration (MIC). 
 Microtiter plate assays 4.1.2
Microtiter plate assays were performed to investigate the potency of plantaricin NC8 and 
the putative plantaricin J51, and if there were any differences between them. By setting up 
MIC assays of each strain, one could also calculate the minimum concentration of each 
bacteriocin (peptides mixed in a 1:1 ratio) necessary to inhibit growth by at least 50% 
(MIC50) in ng/µl. This assay is more informative than the qualitative method of soft agar 
assay. Each experiment was performed at least twice, but the results were similar, so only 
values from one of the experiments are shown here. 
Table 4.2 MIC50 values of the bacteriocin toward selected strains. 
Indicator strain MIC50 in ng/µl2 
PlnJK PLNC8 Putative plantaricin J51 
Lactobacillus casei NCDO 2743 0.5000 0.0078 1 
L. fermentum ATCC 9338 V - 0.0156 0.1250 
L. plantarum 2-1 - 0.0039 - 
L. plantarum 965 0.0039 - 0.0078 
L. plantarum AA23 0.0625 1 0.2500 
L. plantarum DSM 20174 0.0156 - 0.1250 
L. sakei NCDO 2714 - 0.0039 - 
2 “-“ indicates no detectable inhibition 
The microtiter plate assays performed on sensitive wild type strains clearly indicate an anti-
microbial effect of the putative plantaricin J51, although not as potent as the plantaricins 
NC8 and JK. The plantaricins NC8 and JK are active at nano to picomolar range, while the 
putative plantaricin J51 seems to be 10-100 times less potent. The potency of each 
bacteriocin also varies between the strains, with L. plantarum 965 being at least 100 times 
more sensitive for plantaricin JK and the putative plantaricin J51 than rest of the strains. 
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 Function of putative bacteriocin immunity proteins 4.2
In order to study the function of the putative immunity proteins for the bacteriocins 
plantaricin NC8 and the putative plantaricin J51, their cognate immunity genes were cloned 
and heterologously expressed in some of the bacteriocin sensitive strains. In total three 
strains were transformed. L. sakei NCDO 2714 and L. plantarum 2-1 was transformed with 
plNC8c and FLAG™-plNC8c. L. plantarum DSM 20174 was transformed with J51-Orf5.14 
The same assays as performed in section 4.1 was performed again in order to investigate if 
sensitivity to any of the bacteriocins had been changed, and if the previously sensitive strains 
would become immune by the expression of one of the putative immunity genes. Soft agar 
assays were performed first to get an initial picture of any change in sensitivity. Microtiter 
plate assays were performed afterwards to quantify the changed sensitivity levels, and the 
values calculated were used to measure the increase in resistance compared to controls. 
As some of the strains contained immunity proteins with FLAG™-sequences (used for later 
detection and purification of the putative immunity proteins, see section 4.3); assays were 
also performed on strains harboring the FLAG™-sequence and strains without the FLAG™ 
sequence. This was done to investigate if the FLAG™ - sequence would interfere with the 
function of the putative immunity gene, leading to differences in resistance between genes 
with an upstream FLAG™-sequence and genes without the FLAG™-sequence. 
 Soft agar assays of transformed strains 4.2.1
Soft agar assays were first performed to get an overview in change of sensitivity. Both strains 
with and without a FLAG™-sequence were used, and wild type strains without the cloned 
genes were used as controls. Since the used strains are also sensitive to plantarcin JK, it was 
included as well to investigate if the putative immunity genes could confer cross-immunity 
to plantaricin JK as well. 
                                                     
14 A transformed strain with FLAG™-J51-Orf5 was not achieved. 
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Figure 4.2 Soft agar assay of L. sakei NCDO 2714. (A) Wild type strain. (B) Strain transformed with 
plNC8c. (C) Strain transformed with FLAG™-plNC8c. Top row of spots is plantaricin JK, bottom row 
is plantaricin NC8. Concentrations are from left to right: 200ng, 100ng and 50ng in all rows of their 
respective bacteriocins. 
The soft agar assay of the transformed L. sakei NCDO 2714 strains did indicate an increased 
immunity for plantaricin NC8. Any differences in sensitivity between FLAG™ and non-FLAG™ 
constructs were not observed. Cross-immunity was also not observed for plantaricin JK.  
A soft agar assay comparing wild type and transformed strains of L. plantarum 2-1 was also 
performed in order to investigate if the immunity showed any difference between strains. 
 
Figure 4.3 Soft agar assay of L. plantarum 2-1. (A) Wild type strain (B) Strain transformed with 
plNC8c. (C) Strain transformed with FLAG™ plNC8c. Top row of spots is plantaricin JK, bottom row 
is plantaricin NC8. Concentrations are from left to right: 200ng, 100ng and 50ng in all rows of their 
respective bacteriocins. 
The soft agar assay of the transformed L. plantarum 2-1 strains indicates that the immunity 
function of the plNC8c gene is not strain specific. No variance between FLAG™ and non-
FLAG™ constructs were detected. Although it might seem that there are no zones of 
inhibition in the transformed strain when subjected to plantaricin JK, this is not true. Zones 
were observed, but these were hard to capture on camera, partly due to the poor and 
“pelagic” growth of the transformed strains. This indicates that plNC8c does not confer 
cross-immunity to plantaricin JK in this strain as well. 
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 Microtiter plate assays of transformed strains 4.2.2
Microtiter plate assays of transformed strains were performed in order to quantify 
difference in sensitivity between strains harboring the putative immunity genes and those 
that do not. Strains transformed with the empty plasmid pMG36e were used as controls. 
L. sakei NCDO 2714 expressing plNC8c had an eight fold increase in MIC50 compared to the 
empty pMG36e control. L. plantarum 2-1 expressing plNC8c had over a 192 fold increase in 
MIC50, as sensitivity was only detected in the empty pMG36e controls. 
 Protein expression studies 4.3
In order to study the expression of the putative immunity gene plNC8c, protein purification 
combined with SDS-PAGE and different subsequent visualization techniques were employed. 
This was done to investigate if the putative immunity gene is expressed, and also obtain 
information on possible receptors which may co-purify with the immunity protein. A 
previous study that has utilized such an approach has proven successful in revealing new 
information about bacteriocin/immunity receptors, binding and mode of action (Diep et al. 
2007). As the bacteriocin receptor is not known for class IIb bacteriocins, its investigation 
seems warranted. Since the FLAG™-epitope did not interfere with the immunity function of 
the putative immunity gene, it can be used to detect the presence of the putative immunity 
protein (e.g. via binding of an antibody with some sort of reporter), or to directly purify the 
putative immunity protein (e.g. by immunoprecipitation via coupling of the antibodies to a 
solid substrate). 
 A separate culture of L. sakei NCDO 2714 transformed with FLAG™- plNC8c with the 
addition of 62,5ng/ml of plantaricin NC8 was also set up. This was done to hopefully increase 
the expression of the putative immunity gene. L. sakei NCDO 2714 transformed with the 
empty control plasmid pMG36e was also used along with Lactococcus lactis IL1403 harboring 
the gene flciA which was used as a positive control (Diep et al. 2007). The putative immunity 
protein J51-Orf5 was not studied during this part of the study, as FLAG™-J51-Orf5 
transformants were not achieved. For an overview of the abbreviated names used in each 
gel-figure see Table 4.3. 
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Table 4.3 Overview of abbreviated names used in describing samples in upcoming SDS-PAGE 
analyses. 
Strain Construct Presence of 
bacteriocin 
Shortened 
name 
L. sakei NCDO 2714 Empty pMG36e plasmid No e 
pMG36e with FLAG™-plNC8c No -B 
pMG36e with FLAG™-plNC8c Yes +B 
Lactococcus lactis IL 1403 pMG36e with flciA No B244 
 
 Visualization of non-purified versus purified protein extracts 4.3.1
First off, unpurified protein extracts from transformed L. sakei NCDO2714 strains were run 
on 15% acrylamid/bis-acrylamid (40/0.8) separating polyacrylamide gels. These gels were 
visualized using both Coomassie blue staining and immunoblotted using the Western blot 
technique. The reducing chemical 2-mercaptoethanol was not added to the sample buffers 
used, in order to preserve any disulfide bridges present in the samples. The western blots 
revealed very little specific protein present, while the coomassie stained gels indicated huge 
amounts of background. Therefore a purification procedure was employed to hopefully 
obtain more specific protein products, while minimizing background proteins. Purified and 
non-purified extracts were run again on the same gels and Western blots and the results can 
be seen in Figure 4.4 and Figure 4.5 below.  
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Figure 4.4 Coomassie staining of L. sakei NCDO 2714 strains. (Lane 1) Purified B244. (L2) Size 
Marker. (L3) Purified e. (L4) Purified -B. (L5) Purified +B. (L6) Gap. (L7) Non-purified e. (L8) Non-
purified -B. (L9) Non-purified +B. Sizes displayed on the left are in kDa. Approximately 50µg of non-
purified protein fractions were applied on gel. 
Lactococcus lactis B244 expresses the gene flciA (which contains a FLAG™-tag) and is 
approximately the same size as the FLAG™-plNC8 when expressed (12.3kD and 11.5kD 
respectively).  The B244 strain was therefore included as a control.  
The coomassie stained gel revealed a very low grade of purification. A purified amount of 
plNC8c as large as the purified amount of flciA was desired. This was not the case, so a 
Western blot of the same duplicate gel was also performed, in order to hopefully visualize 
the expressed plNC8c gene. 
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Figure 4.5 Western blot of L. sakei NCDO 2714 strains. (Lane 1) Purified B244. (L2) Size Marker, not 
visible. (L3) Purified e. (L4) Purified -B. (L5) Purified +B. (L6) Gap. (L7) Non-purified e. (L8) Non-
purified -B. (L9) Non-purified +B. Sizes shown on the left are in kDa estimated from original 
membrane. Approximately 100µg of non-purified protein fractions were applied on gel. 
A lot of bands were present in Figure 4.4 and Figure 4.5 in the non-purified fractions. The 
Western blot in Figure 4.5 also suggests that the expression of the putative immunity protein 
is very low, as no distinct bands were observed in the expected size range.  
In a previous work by Diep et al. (2007), bacteriocin receptors were identified by co-
purification with the bacteriocin immunity protein and the bacteriocin itself. Such receptors 
could in those studies be identified as additional protein bands when comparing the protein 
profiles of strains with and without the FLAG™-tagged immunity protein. In order to 
investigate if similar results could be obtained for plantaricin NC8, a silver staining procedure 
of purified fractions from L. sakei NCDO 2714 was performed.  
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Figure 4.6 Silver staining of purified samples from L. sakei NCDO 2714 strains15.  (Lane 1) e. (Lane 2) 
-B. (Lane 3) +B. (Lane 4) B244. 
The samples showed very few differences between them and no receptor candidate band 
could be identified. Another SDS-PAGE was performed using a 12% concentration of 
acrylamid/bis-acrylamid (40/0.8). The decrease of acrylamid/bis-acrylamid was done to get a 
better separation of the large bands present in Figure 4.6. The samples were also prepared 
differently using the FastPrep method (see section 3.11.1).  
                                                     
15 Resin purification, SDS-PAGE and silver staining were performed by Senior Engineer Linda Godager 
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Figure 4.7 Silver stained gel of purified samples from L. sakei NCDO 2714 strains. (Lane 1) e. (Lane 
2) –B. (Lane 3) +B. Sizes on the left are indicated in kDa. Only part of marker was present in gel 
after completion of staining. Arrow indicates band cut out for MALDI-TOF analysis. 
The second silver stained gels yielded better separation of the high molecular weight protein 
bands, but still little new information. As the expressed FLAG™-plNC8c immunity gene is 11.5 
kDa, it is not visible in this gel.  
By a detailed analysis of the gel, an additional high molecular weight protein band was 
identified in the strain expressing the immunity protein with addition of bacteriocin (+B). In 
an attempt to identify this band the SDS-PAGE was performed again and stained according 
to Blum et al. (1987). The band indicated by a grey arrow in Figure 4.7 was excised from the 
gel and MALDI-TOF analysis was performed on the fragment according to Shevchenko et al. 
(1996)16. However, no results were obtained from the MALDI-TOF analysis as not enough 
proteins were present. 
                                                     
16 Trypsination was performed by Senior Engineer Morten Skaugen 
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A soft agar assay with spots of resin-putative immunity protein complex was also performed, 
since previous studies by Diep et al. (2007) suggests that the bacteriocin can be co-purified 
along with the immunity protein. However, no anti-microbial activity was detected in this 
study. 
 Investigation of immunity protein complex formation 4.3.2
Suggesting that the FLAG™-plNC8c gene product may form a complex due to the presence of 
two cysteine residues present in the protein, Western blot analyses were performed with 
purified fractions both with and without 2-mercaptoethanol in the SDS-Sample buffer. 2-
mercaptoethanol is known to reduce and thereby break disulfide bonds. 
 
 
Figure 4.8 Western blot of L. sakei NCDO 2714 strains. Lanes 1-5 are samples without 2-
mercaptoethanol. Lanes 7 and 8 are samples with 2-mercaptoethanol. (Lane 1) B244. (L2) Size 
marker, not visible. (L3) e. (L4) -B. (L5) +B. (L6) Gap (L7) -B. (L8) +B. (Arrow 1) Possible complex 
formation. (Arrow 2) Unknown, discussed in section 5.4. (Arrow 3) Possible PLN8C protein. (Arrow 
4) Receptor candidates. (Arrow 5) Unknown, discussed in section 5.4. 
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Figure 4.8 clearly demonstrates a change in band composition between samples with added 
2-mercaptoethanol and without 2-mercaptoethanol. The experiment was performed twice 
and similar results were found. The results from one of the experiments are shown in Figure 
4.8 . Sample B+ without added 2-mercatprothanol shows a high molecular weight band 
(Arrow 1), that is not present in the sample with added 2-mercaptoethanol (2-mercapto +B). 
A strong band present in all samples (also in the empty plasmid strain) matching the size of 
flciA is visible at arrow 2 (discussed in section 5.4). Therefore the bands shown by arrow 3 
are more likely to be the immunity protein. Possible receptor-immunity candidates are 
shown by arrow 4. 
As the Western blot from Figure 4.8 suggested that the putative immunity protein forms a 
complex  (arrow 1 in sample +B with and without 2-mercaptoethanol), a soft agar of L. sakei 
NCDO 2714 transformed with FLAG™-plNC8c as indicator in the presence of DTT was also set 
up. DTT is a reducing agent which breaks any disulfide bonds. This was done to investigate if 
the complex was necessary for the immunity function, as the immunity protein contains two 
cysteine residues (see Figure 5.2). Pediocin PA-1 was used as control as its function is 
dependent on the formation of a disulfide bridge. 
 
 
Figure 4.9 Soft agar assay of L. sakei NCDO 1714 transformed with FLAG™-plNC8c. (A) Without any 
DTT in Soft agar. (B) With 70mM DTT in soft agar. Top row of spots is plantaricin NC8. From left to 
right: 50ng, 100ng and 200ng. Bottom row lefthand corner is Pediocin PA-1 2µl of 50x concentrate. 
Bottom right spot is control spot with dH2O. 
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The soft agar assay indicates that the complex formation might not be necessary for the 
immunity function of plNC8c. Pediocin PA-1 does not exert any anti-microbial activity in the 
presence of DTT, indicating that the cysteine residues have been reduced, and no disulfide 
bridges are present. The sensitivity for plantaricin NC8 is not increased, which indicates that 
a disulfide bridge is not necessary to maintain immunity against plantaricin NC8. If complex 
formation and disulfide bridge establishment is critical for maintaining immunity, larger 
zones of inhibition would be expected in samples with added DTT (Figure 4.9 (B)). 
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5 Discussion 
 Peptide ratio 5.1
Before discussing the main results, the decision to use a 1:1 ratio of each of the bacteriocin 
peptides needs to be discussed. 
Maldonado et al. (2003) suggest that a ratio of 1:16 of NC8α- versus NC8β-peptide is the 
most optimal ratio for plantaricin NC8. These findings are highly debatable as a 1:16 ratio 
seems implausible from a genetical point of view, as both peptides are likely to be translated 
from a single polycistronic mRNA strand. Only one indicator strain was used in that study, 
which cannot rule out strain specific optimal ratios. Unfortunately that indicator strain 
(Lactobacillus plantarum 128/2) is not available in our collection. This could be the reason 
why Maldonado et al. (2003) did not emphasize the strong skewness in the optimal ratio of 
complementary peptides in their article. 
Another comparable finding is the characterization of Lactococcin G. This two-peptide 
bacteriocin was first suggested to have an optimal molar ratio of approximately 1:8 of LcnG-
α versus LcnG-β (Nissen-Meyer et al. 1992). However, further studies indicated that a 1:1 
molar ratio was more probable, based on the fact that both peptides are transcribed from 
the same promoter (Moll et al. 1996). The 1:1 peptide ratio of the peptides comprising 
Lactiococcin G seems to be used in recent studies (Oppegard 2010).  
There have also been a lot of studies on the plantaricins EF and JK. The initial studies 
suggested a 1:1 ratio of each of the complementary peptides as the optimal ratio for anti-
microbial effect (Anderssen et al. 1998). Follow up studies also strengthened that notion 
(Hauge et al. 1999). This 1:1 ratio is also suggested as the optimal ratio for other class IIb 
bacteriocins like Salivaricin P and Lactococcin Q (O'Shea et al. 2010; Zendo et al. 2006). 
There is one striking difference between previously mentioned studies of molar ratios 
between class IIb bacteriocins and this study. In this study synthetic bacteriocins are used 
almost exclusively. Although the manufacturer states that the delivered peptides are 
purified to over 90%, the grade of purity has been shown to vary considerably from 
statements for other peptides used in other studies in the lab (personal communication). 
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Even if the purified single peptide is 90% pure, there is still a chance that the some parts of 
the remaining 10% could be contaminated by the complementary peptide, as the sequences 
from most two-peptide plantaricins are not totally dissimilar (Diep et al. 2009). However this 
type of contamination would be easy to detect as the single peptide solution would probably 
display anti-microbial effects without the addition of the complementary peptide. To 
investigate the grade of purity among synthetic peptides a MALDI-TOF analysis could be 
employed. This analysis could reveal the grade of purity and could maybe determine species 
of any present contaminants. 
Construction of so called isobolograms to determine optimal molar ratio of anti-microbial 
activity for plantaricin NC8 and the putative plantaricin J51 were also attempted 
(Berenbaum 1981). This was done by using soft agar assays to get initial indication of ratios, 
before setting up a microtiter plate assay using serial dilutions of each peptide in separate 
axes. But replicating the results proved difficult, so these results were omitted from this 
study. A 1:1 molar ratio of the peptides was therefore used throughout this study.  
 Bacteriocin sensitivity assays 5.2
 Soft agar assays of wild type strains 5.2.1
In Figure 4.1 the synergistically anti-microbial effect of plantaricin JK is clearly demonstrated. 
As single peptides, none of the spots seem to indicate any inhibition. But when they are 
combined, a zone of inhibition is seen around the spot, although somewhat faint. The same 
is true for plantaricin NC8, but here an even clearer zone of inhibition is observed around the 
spot containing the two complementary peptides. However a distinct zone is also apparent 
in the spot containing only the β-peptide. This could stem from a few reasons. The β-peptide 
could display anti-microbial activity on its own, which is somewhat coherent to the findings 
of Maldonado et al (2003). It seems unlikely that the β-peptide is contaminated by the 
complementary α-peptide (or a similar peptide), as the single peptides constituting 
plantaricin JK and the putative plantaricin J51 does not seem to exert any anti-microbial 
effect on their own. 
Another interesting finding from Figure 4.1 is the zones of inhibition detected when the 
indicator is exposed to both peptides making up the putative plantaricin J51 (J51-Orf3 and 
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J51-Orf4). This is the first time the antimicrobial activity of plantaricin J51 has been 
demonstrated. No inhibition is detected among the single peptides, indicating that both 
peptides are necessary to exert anti-microbial activity. This strongly implies that the putative 
plantaricin J51 has an anti-microbial effect which is very reminiscent of a typical two-peptide 
bacteriocin. This, together with previously determined genetical information deducted by 
Navarro et al. (2008), suggest that the function of these two genes has now been uncovered, 
and their status as putative genes should be removed. A renaming of the two ORFs should 
also be carried out. Some fall pits do exist in assigning a function to these two putative genes 
prematurely; these include impure peptides and other causes which have been discussed 
above (see section 5.1). 
Looking over to Table 4.1, the narrow spectrum of anti-microbial activity typical for class IIb 
bacteriosins is apparent. Plantaricin JK which is known to be produced in several L. 
plantarum strains, seems to inhibit growth mostly in closely related strains and species (Diep 
et al. 2009). The rest of the bacteriocins (plantaricins EF, NC8 and the putative plantaricin 
J51) seem to have a much narrower field of inhibition. 
 Microtiter plate assays of wild type strains 5.2.2
The microtiter plate assays from Table 4.2 seems to follow the same trend as the soft agar 
assays in Table 4.1 (and discussed in section 5.2.1). Plantaricin NC8 seems to be very potent, 
with MIC50 values in the nano- to picomolar range (except for L. plantarum AA-23). The 
plantaricin J51 does not seem to be that potent, with MIC50 values usually in the micro- to 
nanomolar range (with the exception of L. casei NCDO 2743). This could be due to different 
purities in the synthetic peptide solutions (discussed in section 5.1) or simply that plantaricin 
J51 is just not as potent as the plantaricins JK and NC8.  
The MIC50 values for plantaricins JK and J51 with L. casei NCDO 2743 as an indicator might 
seem extreme. But the MIC assays of this strain showed a steady inhibition of growth with 
increasing concentrations of bacteriocin. 
The method of quantitating the MIC50 values using a microtiter plate setup is not perfectly 
accurate. Although reproducibility is fairly good, it can sometimes deviate from previous 
results. Also, only whole wells were used when calculating MIC50 values (e.g. 2 was used 
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instead of 2.5). This is why some of the bacteriocins have a MIC50 value identical to other 
bacteriocins right down to the smallest decimal.  
This is one of the first large scale investigation of sensitivity to plantaricin NC8 (and 
plantaricin J51) conducted to this date, as far as the author knows. This will certainly aid in 
the understanding of the limits of application in which these bacteriocins can be used, and it 
could help to detect a possible receptor for each of the bacteriocins. 
 Function of putative bacteriocin immunity proteins 5.3
 Soft agar assays of transformed strains 5.3.1
In Figure 4.2 clear zones of inhibition are seen in the plate with the wild type strain (A), and 
the strain transformed with plNC8c (B) shows reduced sensitivity as expected. This is easiest 
to observe in the spot containing 50ng of plantaricin NC8, as this zone of inhibition 
completely disappears in the transformed strains. The strain containing a FLAG™ sequence 
upstream of the plNC8c gene (C), have almost the exact same zones of inhibition as the 
transformed strain without a FLAG™ sequence (B). This indicates that the FLAG™ sequence 
in the N-terminal part does not interfere with the immunity from the plNC8c. This plate 
assay also strongly implies that the putative immunity gene plNC8c is in fact an immunity 
gene. Together with the genetic information deducted by Maldonado et al. (2003) suggest 
that function of this putative gene is detected, and its status as a putative gene should be 
removed. 
From Figure 4.2 zones of inhibition when subjected to plantaricin JK are detected among all 
the different plates with the indicator L. sakei NCDO 2714, suggesting that the immunity 
gene plNC8c does not confer cross-immunity to plantaricin JK. This indicates that plNC8c 
specifically confers immunity to plantaricin NC8, and such specificity is a common feature of 
bacteriocin immunity proteins (Cotter et al. 2005). The reason for this specificity is unknown, 
but it could indicate that the bacteriocins recognize different receptors.  
The soft agar assay of the second strain transformed with plNC8c (L. plantarum 2-1), shown 
in Figure 4.3 seems to echo the results from L. sakei NCDO 2714 in Figure 4.2. This indicates 
that the function of the plNC8c gene is not strain specific. However, the transformed L. 
plantarum 2-1 strains ((B and (C) in Figure 4.3) seems to be more immune when exposed to 
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plantaricin NC8, compared to transformed strains of L. sakei NCDO 2714 ((B and (C) in Figure 
4.2).This could be an indication that the expression level of the immunity protein could vary 
between the two strains, or the immunity-receptor interaction could be different between 
the two strains.  
Although it seems that there are no zones of inhibition in L. plantarum 2-1 transformants ((B) 
and (C) in Figure 4.3) when exposed to plantaricin JK compared to the wild type strain, this is 
not true. There are zones of inhibition but this is not very clear from the photographs in 
Figure 4.3. This is also due to the “pelagic” growth sometimes observed in both liquid 
cultures and solid media of L. plantarum 2-1. 
 Microtiter plate assays of transformed strains 5.3.2
The microtiter plate assays results seem to follow the trend from the soft agar assays in 
Figure 4.2 and Figure 4.3. There is a huge difference in sensitivity between the two strains 
transformed with plNC8c. This could mean that another factor is also somehow involved in 
the immunity for plantaricin NC8, and this factor is somehow not present in L. sakei NCDO 
2714. The sensitivity for the transformed strains of L. plantarum 2-1 is in fact so low that no 
sensitivity was detected at all compared to strains harboring the empty pMG36e plasmid. 
This is a bit peculiar as the sensitivity of the wild type strains of L. sakei NCDO 2714 and L. 
plantarum 2-1 does not differ as much. 
Only one clone transformed with J51-Orf5 was achieved, as the other clones sensitive to 
plantaricin J51 were not able to be successfully transformed. Some differences in sensitivity 
were observed between wild type strains and strains transformed with J51-Orf5; however 
these results were not easily reproducible (results not shown). Thus, we cannot conclude 
that J51-Orf5 functions as an immunity protein for plantaricin J51, although this seems very 
likely. 
 Protein Expression studies 5.4
In order to study the expression of the plNC8c gene, SDS-PAGE with different subsequent 
visualization techniques were employed. The initial coomassie staining (as shown in Figure 
4.4) shows few bands in the purified samples, and no clear band with the expressed PLNC8C 
immunity protein, suggesting that the protein expression level is very low. This is a bit 
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peculiar, as the flciA gene which is used as a control (and is situated in the same type of 
vector) is much more easily detected. Therefore the Western blotting technique was 
employed, in hope to better visualize specific bands containing FLAG™ sequences. A silver 
staining method was used for a more sensitive unspecific staining. 
All of the Western blots and silver stained gels (Figure 4.5, Figure 4.6, Figure 4.7 and Figure 
4.8) showed an extremely huge background. This is probably due to a poor or suboptimal 
purification process. In order to improve this, an assay of different detergents used in step 5 
(in section 3.11.3) in the resin binding purification was set up. Solutions ranging from 1-5% 
(v/v) of Triton X-100 and Tween -20 were set up, and the samples were visualized on a silver 
stained polyacrylamide gel (results not shown). However the sample containing 1% (v/v) 
Triton X-100, as used before, seemed to give the lowest background (results not shown). 
Thus the use of 1% (v/v) Triton X-100 was continued. 
Another reason for the poor purification of the FLAG™-tagged immunity protein could be 
that it was expressed at too low levels. The constitutive expression vector used in this study, 
pMG36e with the promoter P32, is optimized for expression in Lactococcus lactis, but has 
been used for protein expression also in Lactobacillus species (Diep et al. 2007; Straume et 
al. 2007). The P32 promoter might not be optimal for this study, resulting in insufficient 
expression levels. 
Also potentially problematic, sequence analyses of the cloned genes used in this study 
revealed a start codon (ATG) upstream of the inserted genes (plNC8c and J51-Orf5). This 
start codon was also present in constructs containing a FLAG™ sequence. However, no stop 
codon was present upstream of the start codon of the inserted genes. Further sequence 
analyses also revealed that a strong Shine Dalgarno sequence, which is necessary for optimal 
ribosomal binding to the transcript, was also present upstream of the “contaminant” ORF. 
This would probably lead to two species of each of the downstream genes; one original gene 
(the immunity gene with or without a FLAG™ tag, depending on construct) and one gene 
with an upstream amino acid sequence of about 18 to 28 aa, depending on construct (see 
Figure 5.1). 
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Figure 5.1 Overview of partial sequence of the pMG36e plasmid containing the FLAG™-plNC8c. 
Translated sequence marked in red, FLAG™-tag marked in green, start codon marked in purple, and 
Shine-Dalgarno sequence is marked in orange. Restriction sites are indicated by names of the 
respective restriction enzymes. 
The presence of two proteins both carrying a FLAG™-tag would definitely impact the 
purification of the protein extracts. Both proteins would probably be purified, resulting in a 
lower concentration of the “true” protein product. This would also lead to a much higher 
background. Since the “contaminant” protein is a bit larger than the FLAG™-PLNC8C protein, 
it should be situated in the same band, or directly above the band containing the FLAG™-
PLNC8C immunity protein. These could be the bands in Figure 4.8 marked by arrows 2 and 3 
(“contaminant protein” and FLAG™-PLNC8C respectively). 
 All in all the extra amino acid sequence present upstream of the FLAG™-tag does not alter 
the function of the downstream immunity proteins. The qualitative data of this study 
remains the same, however some minor deviations in quantification of sensitivity might 
arise.  The “contaminant” protein will however impede the purification process, making it 
more difficult to purify and detect the immunity protein in polyacrylamide gels and Western 
blots. 
Nevertheless, although the background from the purification was high and the protein band 
corresponding to the immunity protein was hard to identify, the immunity observed in the 
tranformant strains indicate that the immunity protein indeed was expressed. These strains 
were therefore used in an attempt to identify the receptors and investigate the immunity 
function. Previous studies by Diep et al. (2007) indicated that the receptor as well as the 
bacteriocin could be co-purified along with the immunity protein. Soft agar assays with spots 
of resin-immunity complex did however not show any anti-microbial activity. This could 
indicate that the concentration of bacteriocins in the immunity-resin complex is so low that 
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anti-microbial activity is not detectable, or that the bacteriocin does not form a complex 
with the immunity protein or another protein bound to the immunity protein. An attempt to 
identify potential bacteriocin receptors by co-purifications were done by comparing silver 
stained gels (Figure 4.6 and Figure 4.7) of purified samples from strains with and without the 
FLAG™-tagged immunity protein (e and –B/+B respectively). However, there were still 
almost no obvious differences in the three samples. 
It was speculated that the putative immunity protein could form a complex with another 
protein, via a disulfide bridge, due to the two cysteine residues present in the putative 
immunity protein. Therefore further Western blot analyses was performed with one set of 
samples containing 2-mercaptoethanol and one set of samples without 2-mercaptoehanol. 
An interesting observation is the strong band present at the very top of lane 5 (>175 kDa, 
indicated by arrow 1) in Figure 4.8. This is a protein sample containing the FLAG™-plNC8c 
with added bacteriocin (in vivo) but without 2-mercaptoethanol. This strong band is 
however not present at the very top in lane 8, which is the same sample just with added 2-
mercatpoethanol. Instead two other bands have appeared, one band with a large protein 
size (46-58 kDa indicated by arrow 5), and one band present in the 10-15kDa area, around 
the same size as the expressed flciA gene (indicated by arrow 3). This same band (in the 10-
15 kDa area) is also present in the other sample containing 2-mercaptoethanol (-B). This 
could indicate that the immunity protein forms a complex with another large protein, via a 
disulfide bond, which is broken when 2-mercaptoethanol is added. This large molecular 
weight band could however not be identified in silver stained polyacrylamide gels (see Figure 
4.6 and Figure 4.7). This is mostly because the silver staining process is unspecific, which 
stains all proteins, and can then potentially mask strong bands observed in Western blots.  
Also observed in the Western blot in Figure 4.8 are two other interesting strong bands that 
appear in the 17 - 25 kDa area (indicated by arrow 4) in samples with added bacteriocin (+B). 
This could be an interaction between the immunity gene and another protein, but this 
interaction does not seem to be affected by the addition of 2-mercaptoethanol. The two 
second lowest bands (residing just above the two bands with similar size as the expressed 
flciA gene) in the two samples containing 2-mercaptoethanol could very well be the 
expressed FLAG™-plNC8c gene. However the signal is very faint for a standard Western blot, 
and a lot of background noise is apparent. 
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As Western blots indicate some sort of a disulfide bridge mediated complex formation, 
between the plNC8c gene and another protein, a soft agar assay with an indicator in the 
presence of DTT was set up. Since the PLNC8C immunity protein contains two cysteine 
residues (see Figure 5.2), a disulfide bridge formation could be very likely. The indicator 
strain is the same strain used in the Western blot analyses (L. sakei NCDO 2714 FLAG™-
plNC8c). Pediocin PA-1, a bacteriocin which has two internal disulfide bridges essential for 
the anti-microbial activity, was used as a control. Figure 4.9 indicates that the complex 
observed in the Western blot in Figure 4.8, might not be necessary for maintaining the 
immunity function of the plNC8c gene, since any disulfide bridges seems to have been 
completely reduced. Peciocin PA-1 does not exert any anti-microbial activity, owing to the 
reduction of its cysteine residues, while sensitivity for plantarcin NC8 has not increased 
(which would be expected if disulfide bridge formation was critical for maintaining the 
immunity function). However further studies should be carried out to clarify this, as the 
design of that soft agar assay may not be optimal (DTT should also be present in the agar 
plates themselves, and a maximum DTT concentration tolerance should be established). 
 
Figure 5.2 Amino acid sequence of PLNC8 in FASTA format showing the presence of two cysteine 
residues (Maldonado et al. 2004). Cysteine residues indicated in red. 
 
 Conclusions 5.5
• Planaricin J51 was established as a novel two-peptide bacteriocin 
• Plantaricins J51 and NC8 have a narrow spectrum of inhibition 
• PLNC8C confers specific immunity to plantaricin NC8 
• Any receptor protein was not identified, but this study suggest that a disulfide bridge 
mediated complex  formation might be involved in the immunity function 
 
>gi|27544862|gb|AAO18428.1| putative immunity protein [Lactobacillus 
plantarum] 
MELLGILSWQESTLEFKAPICSILGVFSVINKFFLKDINFWGWLIVFVFSVKAAVNIDMSSLDWIVQTVF 
TIVSILGICHVLFHKKSFQK 
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 Future work 5.6
As the “contaminant” protein probably has impacted purification and visualization of the 
immunity protein, steps should be taken to eliminate this “contamination”. The immunity 
genes should be cloned into another vector which is free from any contaminating elements, 
preferably with a stop codon just upstream of the inserted gene. The choice of vector should 
also be changed as the pMG36e plasmid is optimized for Lactococcus (Guchte et al. 1989). 
Another vector (like pSIP) should be utilized which is more suitable for Lactobacillus 
plantarum and L. sakei (Sorvig et al. 2005).  
The change of vector should simplify the purification and visualization of the expressed 
immunity genes. MIC assays of transformed strains should be repeated, although huge 
deviations from this study are not expected.  
Hopefully more specific proteins in Western blots and silver stained polyacrylamide gels 
should be present, which might also indicate a good receptor candidate. This receptor 
candidate should be excised from the gel and analyzed using MALDI-TOF to determine its 
identity. 
Another approach to possibly detect and investigate the receptor and immunity function 
might be to generate bacteriocin resistant mutant strains and analyze these. This might also 
give a clue to the mode of action. 
Bacteriocin sensitivity assays should also be performed on known pathogenic strains (like 
Listeria monocytogenes) in order to investigate if the plantaricins NC8 and J51 does exert any 
anti-microbial effect. Although it seems unlikely, any detected sensitivity could be of 
important use in combating the diseases caused by these microorganisms. 
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Plasmid Mini Kit I -  Spin Protocol
Plasmid Mini Kit I Spin Protocol
All centrifugation should be preformed at room temperature unless otherwise noted.  For 
low copy plasmids refer to page 16. This protocol is designed to isolate plasmid from E. 
coli grown in a 1-5 mL LB culture. 
User Supplied Equipment:
•	96-100%	Ethanol	(Do	not	use	denatured	alcohol)
•	Microcentrifuge	capable	of	15,000	x	g
•	1.5	ml	or	2	ml	Centrifuge	Tubes	
•	Appropriate	Centrifuge	Tube	for	step	1
Things to do before starting:
•	Preheat	Elution	Buffer	to	70°C	if	Plasmid	DNA	is	>10kb
•	Prepare	DNA	Wash	Buffer	and	Solution	1	according	to	directions	on	page	6
1. Isolate a single colony from a freshly streaked selective plate, and inoculate a culture 
of 1- 5 ml LB medium containing the appropriate selective antibiotic. Incubate for 
~ 12-16 hr at 37°C with vigorous shaking (~ 300 rpm). Use a 10-20 ml culture tube 
or a flask with a volume of at least 4 times the volume of the culture. It is strongly 
recommended that an endA negative strain of E.coli be used for routine plasmid 
isolation. Examples of such strains include DH5a® and JM109®. 
2. Decant or Pellet bacterial cells by centrifugation at 10,000 x g for 1 min at room 
temperature.
3. Resuspend the bacterial pellet by adding 250 μl of Solution I/RNase A solution, 
and vortexing (or pipetting up and down). Complete re-suspension (no visible cell 
clumps) of cell pellet is vital for obtaining good yields.  Transfer suspension into a 
new 1.5 ml microcentrifuge tube.
4. Add 250 μl of Solution II and gently mix by inverting and rotating tube several times 
to obtain a clear lysate.  A 2-3 minute incubation may be necessary.  Avoid vigorous 
mixing as this will shear chromosomal DNA and lower plasmid purity.  
 
Note:  Do not allow the lysis reaction to proceed more than 5 min. 
(Store Solution II tightly capped when not in use to avoid acidification of Solution II 
from CO2 in the air.) 
5. Add 350 μl of Solution III and mix immediately by inverting several times until a
flocculent white precipitate forms.   
 
Note:  It is vital that the solution is mixed thoroughly and immediately after the 
addition of Solution III to avoid localized precipitation. 
11
6. Centrifuge at 13,000 x g for 10 min at room temperature.  A compact white pellet will 
form.  Promptly proceed to the next step. 
7. Prepare a HiBind DNA Mini Column by placing into a 2 mL collection tube. 
Add 100 μl of Equilibration Buffer.   Centrifuge at 13,000 x g for 30-60 seconds.  
Discard the flow-through liquid and place the HiBind DNA Mini Column back into the 
same collection tube. 
8. Add the cleared supernatant from step 6 by CAREFULLY aspirating it into the 
HiBind DNA Mini Column.  Ensure that the pellet is not disturbed and that no cellular 
debris has carried over into the HiBind DNA Mini Column. Centrifuge at 13,000 x g 
for 1 min  at room temperature to completely pass lysate through the HiBind DNA 
Miniprep Column.  Discard the flow-through liquid and place the HiBind DNA Mini 
Column back into the same collection tube. 
 
9. Add 500 μl of HB Buffer  and centrifuge at 13,000 x g for 30 to 60 seconds at room 
temperature to wash the HiBind DNA Mini Column.  Discard the flow-through liquid 
and place the HiBind DNA Mini Column back into the same collection tube. 
 
This step ensures that residual protein contaminations are removed, thus ensuring 
high quality DNA that will be suitable for downstream applications.  
10. Add 700 μl of DNA Wash Buffer (diluted with absolute ethanol) and  centrifuge 
at 13,000 x g  for 30 to 60 seconds at room temperature to wash the HiBind DNA  
Column.  Discard the flow-through liquid and place the HiBind DNA Mini Column 
back into the same collection tube.  
NOTE:  DNA Wash Buffer Concentrate must be diluted with absolute ethanol before 
use. See label for directions.  If refrigerated, DNA Wash Buffer must be brought to 
room temperature before use.
11. OPTIONAL:  Repeat wash step 10 with another 700 μl of DNA Wash Buffer (diluted 
with absolute ethanol). 
12. Centrifuge the empty HiBind Mini Column at 13,000 x g for 2 min to dry the column 
IMPORTANT:  Do not skip this step - it is critical for good yields
13. Place the HiBind DNA Mini Column into a new/clean 1.5 ml microcentrifuge tube(not 
supplied).  Depending on desire concentration of final product, add 30-100 μl of 
Elution Buffer (10 mM Tris-HCl, pH 8.5) or sterile deionized water directly onto the 
center of the column matrix.  Incubate at room temperature for 1 minute.  Centrifuge 
for at 13,000 x g for 1 min to elute DNA.  An optional second elution will yield any 
residual DNA, though at a lower concentration.
Plasmid Mini Kit I -  Spin Protocol
